Isolation and structure elucidation of bioactive compounds from Euphorbia species by HASH(0x7fe964c89830)
Pharmacognosy Program 
Doctoral School of Pharmaceutical Sciences 
University of Szeged 
 
 
 
 
Isolation and structure elucidation 
of bioactive compounds 
from Euphorbia species 
 
 
 
 
 
 
Ph.D. Thesis 
Norbert Kúsz 
 
 
Supervisors: 
Prof. Judit Hohmann 
Dr. Dóra Rédei 
 
 
 
Szeged, Hungary 
2020 
2 
 
Table of contents 
1. Introduction ......................................................................................................................................... 4 
1.1. Botany of the genus Euphorbia .................................................................................................... 5 
1.1.1. Taxonomic classification of the investigated Euphorbia species .......................................... 5 
1.1.2. Botanical description of the investigated Euphorbia species ................................................ 6 
1.2. Chemical composition of the latex of Euphorbia species, and its role in plant defence ............. 7 
1.3. Euphorbia diterpenoids ................................................................................................................ 9 
1.3.1. Jatrophane diterpenoids ..................................................................................................... 11 
1.3.2. Segetane diterpenoids ......................................................................................................... 14 
1.3.3. Ingenane diterpenoids ......................................................................................................... 15 
1.4. Chemistry and folk medicinal use of the investigated Euphorbia species ................................. 16 
2. Aims of the study ............................................................................................................................... 17 
3. Materials and methods ..................................................................................................................... 17 
3.1. Plant materials ............................................................................................................................ 17 
3.2. Screening of plant materials for diterpenoid content................................................................ 18 
3.3. Extraction and isolation, and preparation of plant extracts ...................................................... 18 
3.3.1. Extraction ............................................................................................................................. 18 
3.3.2. Purification and isolation of compounds ............................................................................. 19 
3.3.3. Preparation of plant extracts for pharmacological screening ............................................. 21 
3.4. Characterization and structure determination of the isolated compounds .............................. 21 
4. Results ............................................................................................................................................... 22 
4.1. Screening of E. dulcis, E. taurinenis, and E. davidii for diterpenoid contents ............................ 22 
4.2. Isolation procedures ................................................................................................................... 22 
4.2.1. Isolation of diterpenoids from E. dulcis ............................................................................... 22 
4.2.2. Isolation of diterpenoids from E. taurinensis ...................................................................... 24 
4.2.3. Isolation of diterpenoids from E. guyoniana ....................................................................... 25 
4.2.4. Isolation of flavonoids from E. davidii ................................................................................. 25 
4.3. Structure determination of the isolated compounds ................................................................ 26 
5. Discussion .......................................................................................................................................... 37 
5.1. Isolation and purification of the diterpenoids and flavonoid glycosides ................................... 38 
5.2. Structure elucidation of the isolated compounds ...................................................................... 39 
5.3. Chemotaxonomical aspects ....................................................................................................... 40 
5.4. Bioactivity of the isolated compounds and plant extracts ......................................................... 41 
5.4.1. Ion channel blocking activity of the diterpenoids ............................................................... 41 
5.4.2. MDR-reversing and cytotoxic activities of diterpenoids isolated from E. taurinensis ........ 43 
5.4.3. Antiproliferative activities of the extracts of E. davidii ....................................................... 45 
6. Summary............................................................................................................................................ 46 
7. References ......................................................................................................................................... 48 
3 
 
Abbreviations and symbols 
1D one-dimensional 
2D  two-dimensional 
CC  column chromatography 
COSY  correlated spectroscopy 
δ  chemical shift 
fr  fraction 
GIRK  G protein-gated inwardly rectifying potassium channels 
hERG  human ether-a-go-go-related gene 
HMBC  heteronuclear multiple-bond correlation spectroscopy 
HSQC  heteronuclear single-quantum coherence spectroscopy 
HPLC  high-performance liquid chromatography 
HRESIMS  high-resolution electrospray ionization mass spectroscopy 
JMOD  J-modulated spin-echo experiment 
MDR  multidrug resistance 
NOE  nuclear Overhauser effect 
NOESY  nuclear Overhauser effect spectroscopy 
NP  normal-phase 
OCC  open-column chromatography 
P-gp  permeability glycoprotein 
PKC  protein kinase C 
PLC  preparative-layer chromatography 
Rf retention factor 
RP  reversed-phase 
SEM  standard error of the mean 
TLC  thin-layer chromatography 
tR  retention time 
VLC  vacuum-liquid chromatography 
Ac  acetyl 
Bz benzoyl 
Cin  cinnamoyl 
iBu. isobutyryl 
AcOAc acetoxyacetyl 
Tig  tigloyl  
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1. Introduction 
The genus Euphorbia belongs to the Euphorbiaceae family, which comprises 5 subfamilies, about 50 
tribes, 300 genera, and 8000 species.1 Euphorbia is among the largest genera of flowering plants with 
approximately 2000 recognized species.2 Plants of this nearly cosmopolitan genus grow throughout 
the world, except in cold, harsh alpine and arctic regions. A comprehensive work written in the last 
decade described 29 Euphorbia species in the Hungarian flora.3 Since then, other invasive Euphorbia 
plants (e.g. Euphorbia davidii, E. serpens, E. prostrata) have also appeared in disturbed habitats of the 
country.4-6 The remarkably diverse growth forms – including geophytes, herbs, shrubs, understory and 
canopy trees, and an array of succulent and xerophytic plants – are the result of evolutionary 
adaptations to different environmental challenges, and serve as a hallmark of the genus.7  
Members of the genus Euphorbia can be characterized by the frequent occurrence of white, milky 
latex. The presence of the exudate is supposed to provide protection against herbivores, insects, and 
microbial phytopathogens.8 Some Euphorbias, such as E. esula, are listed by local authorities as noxious 
weeds, and are required to be eradicated from both public and private properties because of their 
capability to kill livestock.9 In the first edition of Species Plantarum (1753), Carl Linnaeus named the 
genus after an ancient Greek physician, Euphorbus, who successfully treated the severe constipation 
of his king (Juba II, King of Numidia) with the dried sap of a succulent species.1 Many authors believe 
that the plant described in ancient texts as growing abundantly on the slopes of the Atlas Mountains 
was E. resinifera.10 Euphorbia species are collectively known as “spurges”. Their name has been derived 
from the Medieval French word “epurger” (“expurgare” in Latin), referring to the purgative activity of 
the latex and seeds.11 
The traditional medicinal uses of spurge species have a long and rich history. Spurges are commonly 
used in folk medicine for the treatment of microbial (e.g. gonorrhoea, syphilis) and parasitic infections, 
obstipation, asthma, coughs, rheumatism, snakebites, wounds and haemorrhages, eczema, sores, 
warts, and other skin disorders.12 Furthermore, the preparations of “euphorbium” – the sticky gum of 
E. resinifera – have been used against cancers since at least the time of Hippocrates, Galen, and 
Dioscorides.10 Some species (E. kansui, E. pekinensis, E. lathyris, E. humifusa, E. maculata, E. hirta, 
E. ebracteolata, E. fischeriana) have been acknowledged in Chinese pharmacopoeias as valuable 
herbal remedies.13-15 The genus contains many plants of economic importance, such as E. tetragonal 
and E. triangularis (inferior rubber), E. resinifera (euphorbium), E. intisy (intisy rubber), and 
E. antisyphylitica (candelilla wax, E 902).16 Last but not least, some Euphorbia species are cultivated as 
ornamentals, for instance E. pulcherrima (poinsettia, Christmas flower), which is widely used for 
decorating houses during the festive season of Christmas. 
5 
 
In the recent years growing attention has been paid to the diterpenoids, a major class of natural 
products of spurge species. Due to their structural variability and promising bioactivities, Euphorbia 
diterpenoids provide great opportunities for the development of novel drug candidates. In 1995, 
Hohmann et al. (Department of Pharmacognosy, University of Szeged) initiated a research project with 
the aim of investigating the secondary metabolites of Euphorbia species. In the course of those studies, 
a fast and reliable screening method was developed for the detection of diterpenoids, and several 
diterpenoid esters with different skeletons were isolated.17-38 The present thesis summarizes the 
results of the phytochemical analysis of E. dulcis, E. taurinensis, E. guyoniana, and E. davidii, with 
particular focus on their diterpenoid contents. 
 
1.1. Botany of the genus Euphorbia 
The genus Euphorbia is renowned as one of the most diverse groups of the family Euphorbiaceae. 
Despite the highly modified growth forms, all plants in the genus can be characterized by a distinctive 
synapomorphy called as cyathium. The cyathium is a monoecious inflorescence, which name originates 
from the Greek word “kyathos” meaning “cup” or “dipper”.39 The structure of cyathium indeed has a 
cup-like shape, and is composed of an involucre formed by fused bracts, and a single, terminal stalked 
gynoecium (interpreted as a perianthless female flower) surrounded by 4 or 5 lateral clusters of 
stamens (interpreted as reduced male flowers). A series of (usually 4 or 5) nectar-secreting gland 
located at the rim of the cyathial involucre is responsible for attracting pollinators.40  
 
1.1.1. Taxonomic classification of the investigated Euphorbia species 
Order Euphorbiales 
Family Euphorbiaceae 
Subfamily Euphorbioideae 
Tribe Euphorbieae 
Subtribe Euphorbiinae 
Genus Euphorbia 
Subgenus Esula Pers. Chamaesyce Raf. 
Section Helioscopia Dumort. Paralias Dumort. 
Guyonianae 
Molero & Riina 
Poinsettia 
(Graham) Baill. 
Subsection - - - Stormieae Croizat 
Species E. dulcis L.41 E. taurinensis All.41  
E. guyoniana 
Boiss. & Reut.41  
E. davidii Subils.42 
 
The giant genus Euphorbia includes four subgenera: E. subg. Esula Pers., E. subg. Euphorbia, E. subg. 
Chamaesyce Raf., and E. subg. Athymalus Neck. ex Rchb. (also known as E. subg. Rhizanthium (Boiss.) 
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Wheeler).41 The „leafy spurges” term is often used to describe subgenus Esula, because leafy 
herbaceous plants are predominant in this taxon. The subgenus comprises about 480 species, which 
are distributed through Eurasia, but some of its members also occur in Africa and in the New World. 
Subgenus Chamaesyce is the second-most species-rich after subgenus Euphorbia.42 It contains around 
600 species worldwide, and encompasses the largest New World radiation of the genus. Plants in 
subgenus Athymalus (about 150 species) are mostly succulents growing in Africa. Subgenus Euphorbia 
(˃ 600 species) is especially diverse in the arid and semi-arid regions of tropics and subtropics, and is 
well-known for its cactus-like, succulent representatives.7 
 
1.1.2. Botanical description of the investigated Euphorbia species 
Euphorbia dulcis L. (sweet spurge, syn. Euphorbia alpigena A.Kern., E. cordata Schrank, E. deseglisei 
Boreau ex Boiss., E. fallax Hagenb., E. hiberna Lepech., E. incompta Ces., E. lanuginosa Lam., E. patens 
Kit., E. purpurata Thuill., E. solisequa Rchb., E. viridiflora Waldst. & Kit., Galarhoeus dulcis (L.) Haw., 
Pythius dulcis (L.) Raf., Tithymalus alpigena (A.Kern.) Woerl., T. deseglisei (Boreau ex Boiss.) Soják, T. 
dulcis Scop.*) is a more or less pubescent perennial herb with a height of 20-50 cm. The rhizomes are 
long, thicker than the stems, fleshy, swollen, and jointed. The stems are slender, terete, scaly at their 
base, and are approximately 2 mm in diameter. Usually 4-8 axillary rays can be found on a single stem. 
The leaves are 25-70 mm long and have elliptical to oblong shape. The ray-leaves are shorter than the 
rays, like the cauline but wider. The raylet-leaves are triangular-shaped, sub-cordate, and serrated-
edged. The capsules measure 3 to 4 mm in length, are deeply sulcate, glabrous or pubescent, and 
irregularly and sometimes sparsely covered with cylindrical and hemispherical tubercles. The tubercles 
are often filiform. The seeds are 2 × 3 to 2 × 6 mm, smooth, and dark brown. The species occurs in the 
damp and shady places of West and Central Europe and extends southwards to Central Italy and 
Macedonia.43 
Euphorbia taurinensis All. (syn. Esula taurinensis (All.) Fourr., Euphorbia dalmatica Vis., E. graeca Boiss. 
& Spruner, E. lagascae Spruner ex Nyman, E. preslii Spruner ex Nyman, E. serbica Formánek, Tithymalus 
graecus (Boiss. & Spruner) Klotzsch & Garcke, T. taurinensis (All.) Klotzsch & Garcke) is a glabrous 
annual herb with a height of 15 cm. The stems are simple or bear 2 branches at the base, with up to 6 
axillary rays. The shortly petiolate, linear or oblanceolate shaped, entire leaves measure 2-3 cm in 
length and 3.5-5 mm in width. Raylet-leaves are somewhat obliquely rhombic or trullate, acute, and 
subentire. The rays are often much-branched. The capsules are 3 × 3.5 mm, shallowly sulcate, and 
finely granulated on the keels. The seeds are 1.8-2 mm long, ovoid shaped, rather deeply pitted, 
 
* synonym names of plants in the thesis are found at http://www.theplantlist.org/ 
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greyish-white with dark grey discoloration in the pits. This invasive species is native in southern parts 
of Europe and has been introduced into Central and North Europe as well.43 
Euphorbia guyoniana Boiss. & Reut. (syn. Tithymalus guyonianus (Boiss. & Reut.) Klotzsch & Garcke) is 
a dark green herbaceous, glabrous, deciduous plant. The branchy, ascending or erect stems are usually 
30-50 cm tall, but sometimes they can reach up to 1 m in height. Leaves are narrow, linear, alternate, 
the leaf apex is acute or obtuse, and gradually tapers to the tip. As a hemicryptophyte, the plant 
produces perennating buds in order to survive unfavourable conditions. The leaves are often absent 
on the flowering branches, and rapidly dry out at the onset of drought. It has an umbel with 2-3 (rarely 
4-5) rays. Bracts are small and are oval or rhomboid shaped. The smooth capsules are 4 × 5 mm, 
globular, depressed, smooth capsules and have deep longitudinal grooves on their surface.44,45 The 
ecarunculate seeds are ovoid, whitish or greyish, covered by longitudinal denticulate-lacerate wings of 
arillate origin. E. guyoniana grows on sandy dunes on the northern edge of the Saharan Desert and is 
distributed from Morocco to Libya.41 
Euphorbia davidii Subils. (toothed spurge, syn. E. dentata var. gracillima Millsp., E. dentata var. 
lancifolia Farw.) is an annual herb. The stems are solitary, erect, 20-70 cm tall, coarsely or sparsely 
hirsute, and closely strigillose. The branches are usually straight, while the proximal branches are 
occasionally arcuate. The leave blades are 1-10 cm long and 5-35 mm wide, usually stand opposite, 
and sometimes alternate at distal nodes. They have lanceolate to broadly elliptic shape. Ray-leaves are 
narrowly elliptic to lanceolate, shortly petiolate, and paler at their base. The glabrous, 3-lobed, broadly 
ovoid capsules measure 2.9-3.3 × 4-4.8 mm. The seeds display ovoid or triangular-ovoid shape, 
measure 2.4-2.9 × 2.2-2.9 mm in size, angular in cross-section, irregularly tuberculate, and have black, 
brown, or pale grey colour. E. davidii Subils. and E. dentata Michx. (David’s spurge) belong to the E. 
dentata aggregate, and sometimes grow sympatrically. These plants have been widely misidentified 
due to the similarities in their morphology, and because of the recent recognition of E. davidii as a 
separate species. The agricultural weed E. davidii is native in the southwestern United States and 
northern Mexico, elsewhere is adventive; in Europe it has dozens of dispersed populations throughout 
the continent.4,46 
 
1.2. Chemical composition of the latex of Euphorbia species, and its role in plant defence 
Latex is considered to be the most intriguing part of Euphorbia species from the point of view of natural 
product discovery. This aqueous emulsion or suspension is secreted into vacuoles of specialized cells 
called laticifers and contains complex mixtures of pharmacologically active compounds including 
terpenoids, proteins, carbohydrates, and amino acids. The latex is held under pressure, and 
immediately oozes out in case of an injury. Previously, several hypotheses have been proposed to 
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explain the function of latex, like storage of plant nutrients, deposit of waste products, or water 
reserve. Nowadays it is generally accepted that latex plays a major role in plant self-defence 
mechanisms.47 Latices often contain specialized defensive metabolites at much higher concentrations 
compared to other plant organs.48 This fact, along with the localization of toxic diterpenoids to young 
stems and roots, strongly supports this theory.49 
Serine and cysteine proteases are frequently present in the latex of Euphorbia species.50 They are 
considered to promote coagulation processes after an injury, and therefore the formed clot could 
prevent infections by sealing the damaged area. Due to the procoagulant activity of these enzymes, 
Euphorbia latices have traditionally been applied to fresh cuts in order to stop bleeding.51 The so-called 
pathogenesis-related proteins, involving lysozyme and various chitinases are de novo synthesized 
under stressful conditions, and serve the purpose of overcoming attacks of pathogens, drought, or 
wounding.52 Lectins with selective affinity for particular sugar molecules represent a further fraction 
of proteins in the sap. A galactose-specific lectin purified from the latex of E. antiquorum is reported 
to exert bacteriostatic activity by binding to carbohydrates of the bacterial cell wall, which results in 
drastic changes in cell morphology.53 
The stickiness of latices stems from the presence of polyisoprenoids which, together with proteolytic 
enzymes, enable rapid wound closure. The viscous latex also acts as a physical barrier against insects 
by deterring or trapping them. Rubber built up by cis-1,4-isoprene units is one of the most abundant 
polymeric terpenoid in spurge species.54 Di- and triterpenoids are also major components of the latex. 
Bigonija et al. analysed the chemical composition of the latex from E. neriifolia, and reported total di- 
and triterpenoid contents of the solid particles of 24.50% and 16.23%, respectively.55 Triterpenoids 
isolated from Euphorbia latices to date are mostly tetracyclic euphanes, tirucallanes, and cycloartane 
derivatives,56,57 although some spiro-,58 seco-,56 and acyclic compounds59 have also been identified. 
Despite the considerable amounts of triterpenoids in rubbery latices, their contribution to the plant’s 
defence mechanisms remains to be determined. Nevertheless, it has been shown that triterpenoids 
are able to incorporate into the lipid bilayer of cell membranes.60 This might increase membrane 
permeability of phytopathogens for smaller toxic hydrophilic (e.g. phenolic) compounds.54 Smaller 
isoprenoids, such as sesquiterpene hydrocarbons (β-caryophyllene, α-humulene, α-copaene)61 and 
dihydroionol-type bisnorsesquiterpenoids62 were reported from the latex of some spurges. 
Diterpenoids represent the most diverse group of secondary metabolites of Euphorbia plants. Without 
being exhaustive, diterpenoids have been described to possess antifungal,63,64 antifeedant,65 and 
molluscicidal66 activities. Krstić et al. have recently investigated the fungal infection-induced metabolic 
changes in the latex of E. palustris.67 It was found that the concentrations of antifungal metabolites, 
benzoyl ingenol-laurate and 24-methylenecycloartanol, increased in the infected plants; notably, the 
level of benzoyl ingenol-laurate was 20-fold higher compared to healthy plants. In addition, tigliane, 
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daphnane, and ingenane diterpenoids, collectively referred to as “phorboids”, exhibit strong skin- and 
mucosa-irritating and pro-inflammatory activities.68 Besides phorboids,69-74 jatrophane,75-85 
lathyrane,70,86 ingol,70,87,88 and rhamnopholane87 diterpenoids were also isolated from the latices. 
 
1.3. Euphorbia diterpenoids 
Spurge species are prolific producers of a diverse range of diterpenoids, which can be broadly classified 
into two main groups: ‘higher diterpenes’ are formed from the common precursor geranylgeranyl 
pyrophosphate (GGPP) through classical, concertina-like cyclizations typical of many triterpenoids and 
steroids, while ‘lower diterpenes’ are derived by cyclizations after the loss of a diphosphate group and 
alkylation one of the double bonds.89 In the genus Euphorbia higher diterpenes are mainly represented 
by labdanes, kauranes, atisanes, pimaranes, and abietanes. In contrast to non-specific higher 
diterpenes, lower diterpenes (also known as macrocyclic diterpenes) are not widely distributed in the 
plant kingdom. Cembrane diterpenes mainly occur in members of Euphorbia and Nicotiana genera, in 
the oleoresins of Pinus species, and in various marine organisms (soft corals, etc.).90 Cyclic products of 
the cembrane class are important chemotaxonomic markers, because their occurrence is mostly 
limited to the families Euphorbiaceae and Thymeleaceae.91 The blanket term ‘macrocyclic diterpenes’ 
might be deceptive, as it is used to describe compounds with actual macrocycles (e.g. jatrophanes) and 
their polycyclic derivatives (e.g. ingenanes) as well. 
The hypothetical biosynthetic pathways of macrocyclic diterpenes are shown in Figure 1. Thanks to 
the studies of recently identified enzymes responsible for initiating the cyclization processes, the 
conversion of GGPP into casbene has been clarified. First, a reactive cembrene cation is formed from 
GGPP by the loss of a diphosphate moiety, then it readily undergoes cationic cyclizations and 
subsequent Wagner-Meerwein rearrangements.92 CYP450 enzymes catalyse a further series of 
oxidative reactions on the hydrocarbon backbones.93 Transannular cyclizations and ring openings, as 
well as esterification of the oxidized cores with a wide range of organic acids bring about 
unprecedented chemical diversity. However, in spite of the obvious structural similarities between 
macrocyclic skeletons, the production of advanced intermediates is still poorly understood. 
The first known macrocyclic Euphorbia diterpenoid, euphorbiasteroid, was isolated in 1937 from the 
seed oil of E. lathyris.94 As its name implies, it was originally thought to be a steroid, but later the 
structure was unambiguously determined as 6,17-epoxy-lathyrol.95 Jatrophone, the first jatrophane 
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Figure 1. Plausible biosynthetic routes of macrocyclic diterpenes96-101 (cycl.: cyclization, rearr.: rearrangement, 
op.: opening, form.: formation). Some authors suggest that the lathyrane skeleton is directly formed from 
casbane by cyclization between C-4 and C-15.68 (For certain macrocycles, the principles 
of numbering differ, thus the numbering method of jatrophanes is used here for the sake of clarity.) 
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diterpenoid was discovered from Jatropha gossypiifolia in 1970.102 Ingenol, the parent compound of 
ingenane diterpenoids was identified in 1968 by Hecker et al. as a chemical constituent of E. ingens.94 
Two years later the structure of its triacetate was elucidated through single-crystal X-ray analysis.103 
Since that time, Euphorbia species have been the subject of extensive phytochemical investigations 
leading to the isolation of hundreds of new diterpene derivatives with more than 20 different 
skeletons.91  
 
1.3.1. Jatrophane diterpenoids 
Jatrophanes are synthesized in a number of Jatropha and Euphorbia species.104 These plant 
metabolites are characterized by a highly oxygenated trans-bicyclo[10.3.0]pentadecane skeleton 
wherein three methyls are located at C-2, C-6, and C-13, and a gem-dimethyl group at C-10. Jatrophane 
diterpenoids usually occur in the form of polyesters. Acetyl, benzoyl, nicotinoyl, propyl, isobutyl, 2-
methylbutyl, angeloyl, tigloyl, and cinnamoyl groups are the most frequent acyl residues. The number 
and positions of the double bonds and oxygen functions, as well as the esterification pattern can differ, 
which considerably increases the chemical variability of jatrophanes. 
Hydroxy groups are most often found at C-3, C-5, C-7, C-9, and C-15, and in some cases at C-1, C-2, C-6, 
C-8, C-11, C-13, C-14, and C-17.105 The unusual presence of an OH group at C-4 was only reported in 
pubescenol (Figure 2, compound a).106 Keto groups are usually attached to C-9 and/or C-14. 
Jatrophanes containing a 11,12-epoxide ring were reported from E. lateriflora,76 E. welwitschii,107 
E. salicifolia,25 E. kansui,108-110 and E. esula (Figure 2, b).17,111 Jatrophanes of E. mongolica,36 
E. characias,75 and E. connata112 have a unique 5,6-epoxide structural part. Some of the jatrophane 
derivatives bear hemiketal moieties. Compounds with an ether bond between C-11 and C-14 are 
characteristic of E. kansui108-110 (Figure 2, c) and E. esula.17,32,111 Furthermore, some diterpenoids 
obtained from E. serrulata23,28 (Figure 2, d) and E. platyphyllos29 possess a 6,9-hemiketal, while 
jatrohemiketal from E. amygdaloides incorporates a tetrahydropyran ring formed between C-9 and C-
17 (Figure 2, e).113 The presence of an ether bridge connecting C-12 and C-15 is quite rare among the 
jatrophanes.102,107,114 Terracinolides identified from E. terracina (Figure 2, f),115,116 E. sororia,117 
E. dendroides,80,83 and E. segetalis118 are based on a C22 17-ethyl bis-homojatrophane framework 
featured by a δ-lactone. In the structural isomers isoterracinolides isolated from E. terracina,119 
E. guyoniana,120 E. exigua,37 and E. sororia (Figure 2, g),117,121 and in salicinolide isolated from 
E. salicifolia,26 the 8-membered lactone rings are closed between the two-carbon fragment attached 
to C-17 and the oxygen function at C-3 or C-9, respectively. 
The great majority of jatrophanes contain a 6(17)-exomethylene group. Jatrophane diterpenoids can 
be categorized as exo- and endo-conformers based on the spatial orientation of 6(17)-exomethylene 
12 
 
with respect to the mean plane of the macrocycle.83 In the more common exo-form the exomethylene 
points outward, thus it is parallel with the mean plane of the twelve-membered ring, while in the endo-
type conformation it is perpendicular to the plane. The 3JH4-5 coupling constant is either small (0-3 Hz 
– exo) or large (9-11 Hz – endo) depending on which conformer the particular diterpenoid adopts.83,122 
In an exo-conformer the adjacent H-4 and H-5 protons are almost orthogonal to each other, while in 
an endo-conformer they are antiperiplanar. Besides the common endocyclic Δ(11,12) double bond, olefin 
groups are sometimes formed between C-4/C-5,24 C-5/C-6,24 C-7/C-8,19 and C-12/C-13.123 Jatrophanes 
of Pedilanthus tithymaloides contain rare Δ(3,4) and/or Δ(6,7) double bonds (Figure 2, h).124 
 
Figure 2. Selected diterpenoids illustrating the chemical diversity of jatrophanes. 
 
Several modified jatrophane derivatives are reported in the literature. Heliojatrones A–C with an 
unprecedented trans-bicyclo[8.3.0]tridecane scaffold were isolated from E. helioscopia (Figure 3, 
i).125,126 Abeo-jatrophanes constitute an extraordinary group of rearranged diterpenoids. It is 
postulated that 1(15→14) abeo-jatrophanes might arise from a pinacol-type rearrangement.105 
Although this kind of reaction could possibly occur in all of the 14-keto-15-hydroxy jatrophanes, to the 
best of our knowledge, until now such compounds have only been detected in E. dendroides (Figure 3, 
j) and E. terracina.80,127 Euphosalicin isolated from E. salicifolia is the only known 9(10→18) abeo-
jatrophane.25 Heliosterpenoids A and B obtained from E. helioscopia, and gaditanone derived from E. 
gaditana (Figure 3, k), possessing a novel 5/6/4/6-fused tetracyclic ring system, are presumably 
formed from a general jatrophane skeleton via intramolecular [2 + 2] cycloadditions between the 
positions 5 and 12, and 6 and 11.128,129 Euphowelwitschines A and B are interesting 12,17-
cyclojatrophanes having an additional tetrahydrofuran ring.107 Salicifoline isolated from E. salicifolia is 
another 12–17-cyclo-derivative with an epoxy function.26 Secoheliosphanes A and B are based on an 
unusual 7,8-seco jatrophane skeleton (Figure 3, l).130 Moreover, in a very recent study E. helioscopia 
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has been reported to contain two novel diterpenoids based on a 4-(5,5-dimethylheptan-2-yl)-2,7-
dimethylbicyclo[4.3.0]nonane framework (Figure 3, m).131 Guided by the presence of the 3,3-
dimethylhept-4-en-2-one side chain, which is a common structural fragment of the 12-membered 
macrocycle, the authors concluded that these compounds might be converted from the co-occurring 
jatrophanes euphoscopin A and epieuphoscopin A. 
 
Figure 3. Examples of rearranged jatrophane derivatives. 
 
Jatrophane diterpenoids do not form a stereochemically homogeneous series, because the 
configurations of asymmetric carbons are variable. Findings from current studies investigating the 
absolute configuration of jatrophanes by X-ray diffraction or circular dichroism are in line with previous 
reports: H-4 is α, and 15-OH or 15-acyl group is β in all of the natural  
jatrophanes.83,117,129,132-134 
The fascinating structures of jatrophanes give rise to complex interactions with living organisms. 
Jatrophanes might be best known for their MDR modulator activity. This noteworthy feature of 
jatrophanes was first reported by Hohmann and co-workers,24 followed by a number of published 
articles in the past 17 years. Recent findings also support the promising MDR modulator role of 
jatrophanes. Their MDR reversing effects on cancer cell lines of different origin are often as good as 
that of the positive controls verapamil79,85,134 or cyclosporin,125,132 while even compounds exerting 
many-times stronger activities have also been described.117 The fruits of E. sororia afforded a 
jatrophane which significantly enhanced the effect of vinorelbine against KBv200 cell xenografts in 
nude mice.135 Macrocyclic diterpenoids of Euphorbia species are proven to be potent inhibitors of MDR 
proteins of Candida albicans; substantial decrease in yeast growth was observed at submicromolar 
concentrations of these terpenoids in the presence of fluconazole.84,136 Besides inhibiting P-
glycoprotein-mediated drug resistance, some jatrophanes also synergize with paclitaxel,137 
doxorubicin,138 and epirubicin.139 Further jatrophane diterpenoids exerting strong proapoptotic effects 
on human gastric and pancreatic tumor cells, as well as on ovarian cancer cell lines were isolated from 
E. welwitschii,138 E. osyridea,140 and E. cyparissias,141 respectively. Jatrophanes from E. dendroides are 
reported to exert anti-angiogenic activity by decreasing the secretion of vascular endothelial growth 
factor,142 while macrocyclic diterpenoids yielded from the Sardinian endemic species E. semiperfoliata 
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were found to interact with tubulin polymerization.143 Pešić et al. have concluded that the synergism 
between paclitaxel and jatrophanes is partly due to their mutual effects on microtubule assembly that 
leads to cell cycle arrest at the G2/M phase.142  
However, the scientific merit of jatrophane diterpenoids is not limited to their anticancer properties. 
The jatrophane esters isolated by bioassay-guided purification of the EtOAc extract of E. amygdaloides 
ssp. semiperfoliata inhibit the replication of HIV-1, HIV-2, and chikungunya viruses.144 Bedoya et al. 
reported that a jatrophane of E. hyberna, assigned as SJ23B, prevents the viral infections of human 
primary T cells at nanomolar concentrations by inducing the internalization of HIV-1 receptors, and 
suggested that the activation of classical PKCs might explain the mitigation of viral reservoirs.145 E. 
helioscopia furnished a jatrophane polyester that exerts significant antimicrobial activity against the 
oral pathogens Streptococcus mutans and Actinomyces viscosus.146 The polyacylated diterpenoids of 
P. tithymaloides show pronounced antiplasmodial activity, and one of the tested compounds was 
found to be moderately effective against Mycobacterium tuberculosis.147 Jatrophone and some of its 
semisynthetic derivatives, together with euphorbesulin G from E. esula display notable activity against 
Plasmodium falciparum strains.148,149 Jatrophanes of E. kansui,150 E. helioscopia,151,152 and E. peplus153 
are potent inhibitors of the lipopolysaccharide-induced production of NO, which is a key signalling 
molecule in the pathogenesis of inflammation. In other experiments jatrophanes exerted lipid 
lowering,133 neuroprotective,109,132,152 and vasodepressor effects.154 
 
1.3.2. Segetane diterpenoids 
Segetanes, a unique class of Euphorbia diterpenoids are characterized by a modified jatrophane core 
incorporating a bicyclo[4.3.1]decane ring system. Prior to our research work, only 12 segetanes had 
been identified from E. segetalis (Figure 4, n),118 E. paralias,155-158 E. portlandica,159 and E. peplus.153 
Segetanes might be synthetized from jatrophane precursors via two-step transannular cyclization 
processes. Jakupovic et al. proposed that the first step could be an intramolecular C–C bond formation 
between C-8 and C-12, which would yield a tricyclic intermedier called presegetane. Later on this 
hypothesis was reinforced by the presence of presegetane diterpenoids in E. esula and E. paralias 
(Figure 4, o).149,158 A related isomer, 15-epi-presegetane with an inner ketal structural part was 
obtained from E. segetalis (Figure 4, p).118 The second step of biosynthesis is most likely a subsequent 
ring closure occurring between C-13 and C-17. An alternative approach was reported by Wang et al., 
who achieved the single-step Diels-Alder synthesis of a segetane diterpenoid from a jatrophane 
precursor.153 Due to the limited number of studies, knowledge on the pharmacological properties of 
segetane diterpenoids is scarce. Compounds of this group are reported to possess in vitro anti-
inflammatory and MDR modulating activities.153,159 
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Figure 4. Some of the segetanes and segetane-related diterpenoids. 
 
1.3.3. Ingenane diterpenoids 
The intriguing group of ingenane diterpenoids are based on a bicyclo[4.4.1]undecane-11-one core with 
a highly strained inside-outside trans-intrabridgehead stereochemistry.160 This structural feature is 
very rare in natural compounds: apart from the ingenanes, seco-trinervitane diterpenoids isolated 
from nasute termite species are the only examples displaying in/out stereochemistry.161 The chemical 
structures of ingenanes are far less diverse compared to jatrophanes. The skeleton of ingenane  
diterpenes isolated to date always comprises a Δ(1,2) and a Δ(6,7) endocyclic double bond. The 
cyclopentane and cycloheptane rings in the 5/7/7/3-tetracyclic ring system are trans-fused.162 A 
β-hydroxy group is linked to C-4, and other oxygen functionalities are usually found on C-3, C-5, C-13, 
C-17, and C-20. The hydroxy moieties are esterified with acetyl, angeloyl, dimethylbutanoyl, and 
benzoyl groups, or long-chain (octanoyl, decanoyl, decadienoyl, tetradecadienoyl, dodecanoyl, 
myristoyl, palmitoyl etc.) fatty acids. Ingenanes from E. cornigera contain N-(2-
aminobenzoyl)anthraniloyl moieties (Figure 5, q),66 while E. milii and E. leuconeura afforded ingenanes 
with unique tri-anthraniloyl peptides attached to the diterpenoid core at C-3 (Figure 5, r).70,163 An 
ingenane, euphorkanlide A isolated from E. kansuensis contains a quite strange C24 appendige, which 
forms a hexahydroisobenzofuran-fused 19-membered macrocyclic bis-lactone ring system (Figure 5, 
s).164 
 
Figure 5. Ingenane diterpenoids with unique side chains. 
Ingenol mebutate is definitely the most prominent member of ingenanes. Ingenol mebutate, or 
ingenol 3-angelate is the active principle of the commercially available Picato® gel, approved by the 
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U.S. Food and Drug Administration (FDA) in 2012 and the European Medicines Agency (EMA) in 2013 
for the topical treatment of actinic keratosis, a common premalignant skin-condition.89 The presence 
of ingenol mebutate in E. peplus was first reported by Hohmann et al. during a screen of Hungarian 
Euphorbia species.22 It had previously been isolated from other Euphorbias (E. antiquorum, 
E. helioscopia, and E. paralias), too. Due to the unusual structural elements of the parent compound 
ingenol, including the congested 3β,4β,5β-triol part, an adjoining quaternary stereocenter and a 
dimethylcyclopropane moiety, the synthesis of ingenol mebutate is extremely challenging.165 Currently 
the general source of ingenol mebutate is E. peplus.166 
The C-3 monoesters of ingenol, together with structurally related phorbols, are potent tumor 
promoter and pro-inflammatory agents. Their carcinogenic and irritant properties have been shown 
to correlate with the length of the aliphatic chain: compounds with longer ester groups were found to 
be more toxic.167 Ingenol mebutate bearing a smaller C-3 angeloyl group has anticancer activity, 
mediated by a dual mechanism. First, it induces the translocation of pro-apoptotic intracellular PKC 
into cytoplasmic and nuclear membranes, which ultimately leads to rapid mitochondrial disruption and 
the consequent apoptosis of dysplastic keratinocytes.168 In addition to its necrotic effect, ingenol 
mebutate promotes the infiltration of neutrophils into the affected areas, which then eliminate 
malfunctioning epidermal cells by antibody-dependent cellular cytotoxicity. Ingenol 3,20-dibenzoate 
is a noteworthy compound because, in sharp contrast to other 3-acyl esters of ingenol, it is able to 
selectively activate the novel forms of PKCs. The activation of this class of enzymes has been associated 
with in vivo thrombopoietic effects, therefore the dibenzoate derivative of ingenol may represent a 
novel strategy for alleviating bone marrow damage caused by toxic anticancer agents.169 Recent 
studies have also reported antinematodal,170 anti-HIV,171,172 cytotoxic,173 and interferon gamma (INF-
γ) production modulating activities174 of ingenane diterpenoids. 
 
1.4. Chemistry and folk medicinal use of the investigated Euphorbia species 
The chemical constituents of E. dulcis have only been investigated by Pohl et al., who isolated 
quercetin-3-O-β-glucoside, quercetin-3-O-β-galactoside and quercetin-3-O-β-galactoside-6"-gallate 
from the plant.175 Phytochemical screening revealed the presence of sterols, carotenoids, tannins, 
flavone glycosides, and anthocyanosides in different parts of E. guyoniana.176 Boudiar et al. reported 
the isolation of a new alkaloid, 1,5-diphenyl-3-styryl-2-pyrazolin, and six known flavonoids 
(kaempferol, quercetin, and their glycosides) from the acetone extract of aerial parts of 
E. guyoniana.177 Diterpene content of E. guyoniana of Algerian origin was also examined earlier, and 
ent-abietane, atisane, jatrophane and tigliane type diterpenes were isolated from the roots,178,179,180 
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as well as the jatrophanes guyonianin A–F from the aerial parts.120,181,182 To the best of our knowledge, 
no data had been previously published on the chemical compositions of E. taurinensis and E. davidii. 
In the Algerian and Tunisian folk medicines preparations of E. guyoniana have long been used for the 
treatment of pain, cough, diarrhoea, wounds, warts, skin diseases, stings of venomous scorpions, and 
snakebites.120,183 E. dulcis, E. taurinensis, and E. davidii are not used in traditional medicine. 
 
2. Aims of the study 
As a part of ongoing research, the goals of my work were the isolation and structure determination of 
new diterpenoids, followed by the investigation of their bioactivity, executed in collaboration with 
cooperative partners. In order to meet these objectives, the main tasks were as follows: 
• Screening of E. dulcis, E. taurinensis, and E. davidii for their diterpenoid contents (diterpenoids 
have previously been described from E. guyoniana, thus screening of this Saharan species was 
unnecessary). 
• Extraction of the plant materials of E. dulcis, E. taurinensis, E. guyoniana, and E. davidii. 
• Isolation and purification of the diterpenoids by various chromatographic methods (polyamide 
OCC, VLC, PLC, and HPLC). 
• Structure elucidation of the diterpenoids by means of advanced spectroscopic techniques  
(1D- and 2D NMR, HRMS, single-crystal X-ray diffraction). 
• Assessment of the chemotaxonomic importance of the isolated compounds. 
• Evaluation of the pharmacological properties of diterpenoids (GIRK- and hERG channel 
inhibitory activity, MDR modulation, cytotoxicity). 
 
3. Materials and methods 
3.1. Plant materials 
E. dulcis: Whole plants (3.8 kg) were collected in the flowering period at Homoródalmás, Romania, in 
July 2014. The plant material was identified by Dr. Gusztáv Jakab (Institute of Environmental Sciences, 
Szent István University, Szarvas, Hungary). The fresh plant material was frozen and stored at –20 ˚C 
until extraction. 
E. taurinensis: Whole plants (1 kg) were collected in May 2014, in Budapest, Hungary (at latitude 
47°27’35’’ N and longitude 19°3’34’’ E) and identified by Dr. Zoltán Barina (Department of Botany, 
Hungarian Natural History Museum, Budapest, Hungary). The phytochemical analysis of E. taurinensis 
was immediately started after harvesting the plants. 
E. guyoniana: Aerial parts were gathered in 2013 in southern Tunisia, specifically from the droughty 
natural region called Grand Erg Oriental. The plant material was identified by Dr. Mohamed Chaieb 
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(Department of Biology and Ecology of Arid Land, University of Sfax, Sfax, Tunisia). Aerial parts were 
dried at room temperature (45 g). 
E. davidii: Whole plants (15 kg) were collected near Igar, Hungary in September 2011, and identified 
by Dr. Gyula Pinke (Department of Botany, University of West Hungary, Mosonmagyaróvár, Hungary). 
The fresh plant material was stored at –20 ˚C until further preparation. 
Voucher specimens of E. dulcis, E. taurinensis, and E. davidii (numbers: 838, 879, and 836, respectively) 
have been deposited in the Herbarium of the Department of Pharmacognosy, University of Szeged, 
Szeged, Hungary. A voucher specimen of E. guyoniana has been retained under the name of EUPH 07 
in the Herbarium of University of Sfax, Sfax, Tunisia. 
 
3.2. Screening of plant materials for diterpenoid content 
The plant samples of E. dulcis, E. taurinensis, and E. davidii (each 50 g) were crushed and thoroughly 
extracted with MeOH (500 mL) in an ultrasonic bath (45 min) at room temperature. The concentrated 
extracts were diluted with H2O (30 mL), and then subjected to solvent-solvent partitioning with CHCl3 
(3 x 50 mL). The CHCl3-soluble phases were separated by polyamide OCC using gradient solvent 
systems of MeOH–H2O [3:2, 4:1, and pure MeOH (each 150 mL); mobile phases are given in terms of 
volume ratio, v/v]. The collected fractions were developed in cyclohexane–EtOAc–EtOH (30:10:1) and 
were visualized by cc. H2SO4 followed by heating at 110 ˚C for 2 minutes. 
 
3.3. Extraction and isolation, and preparation of plant extracts 
3.3.1. Extraction 
The frozen plant material of E. dulcis and the fresh parts of E. taurinensis were crushed with a Waring 
CB-6 commercial blender (model 33BL13) and exhaustively percolated with MeOH (30 L and 10 L) at 
room temperature. The extracts were concentrated in vacuo by a Büchi Rotavapor R-200 (40 ˚C, 337 
mbar) and resuspended in H2O (500 mL and 300 mL) prior to liquid-liquid partitioning with CHCl3 (5 x 
500 mL and 6 x 300 mL). 
The air-dried herbal sample of E. guyoniana was powdered with a Bosch MKM 6000 grinder. The raw 
material was extracted with CHCl3 (3 x 300 mL) in an ultrasonic bath (3 x 15 min) at room temperature. 
The extracts were concentrated in vacuo (30 ˚C, 474 mbar). 
The frozen plant parts of E. davidii were crushed with a Waring CB-6 blender and extracted with MeOH 
(15 L) at room temperature. The solvent was evaporated in vacuo (40 ˚C, 337 mbar). After 
concentration, the crude residue was diluted with water (1000 mL), and then subjected to repeated 
solvent-solvent extraction using CHCl3 (5 x 1500 mL) and EtOAc (5 x 1000 mL). 
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3.3.2. Purification and isolation of compounds 
Open-column chromatography: OCC was performed on polyamide (MP Polyamide, 50-160 μm, MP 
Biomedicals) for column chromatography (220 g, 70 g, and 6 g for the plant extracts of E. dulcis,  
E. taurinensis and E. guyoniana, respectively). The crude extracts were dissolved in CHCl3 and adsorbed 
onto polyamide. The organic solvent was completely eliminated in a ventilated hood, and the obtained 
powdery materials were loaded into chromatographic columns. The plant extracts were eluted with 
mixtures of MeOH–H2O [3:2 and 4:1 (E. dulcis: 4500 and 2200 mL, E. taurinensis: 400 mL each, E. 
guyoniana: 50 mL each)]. 
Vacuum-liquid chromatography: For VLC, silica gel (Kieselgel GF254, 15 μm, Merck) and RP silica gel 
(LiChroprep RP-18, 40-63 μm, Merck) were used. The extracts were dissolved in CHCl3 and adsorbed 
onto one-tenth of the silica, then the organic solvent was completely removed in a ventilated hood. 
The dry-packed columns were prepared by filling the remaining silica gel into glass filter funnels 
containing fritted discs (G3) at their bottom. The powders of extracts were placed at the top of the 
stationary phase. The VLC columns were developed under gentle vacuum provided by a semi-
automatic Büchi V-800 Vacuum Controller. The collected fractions were combined in accordance with 
their chemical compositions monitored by TLC. 
➢ Fractionation by VLC on normal phase silica gel 
Column 1 eluent: cyclohexane–EtOAc–EtOH (70:10:0, 60:10:0, 50:10:0, 50:10:1, 40:10:1, 
30:10:1, 20:10:1; 200 mL each); volumes of collected fractions: 25 mL; sorbent: 
75 g 
Column 2 eluent: toluene–CHCl3–Me2CO (70:10:1, 50 mL; 60:10:1, 50 mL; 50:10:1, 50 
mL; 40:10:1, 50 mL; 30:10:1, 100 mL; 20:10:1, 100 mL; 10:10:1, 50 mL); 
volumes of collected fractions: 15 mL; sorbent: 25 g 
Column 3 eluent: cyclohexane–EtOAc–EtOH (80:10:0, 60:10:0, 40:10:0, 30:10:0, 20:10:0, 
20:10:2; 120 mL each); volumes of collected fractions: 10 mL; sorbent: 50 g 
Column 4 eluent: cyclohexane–EtOAc–EtOH (60:10:0, 40:10:0, 30:10:0, 30:10:1, 30:20:1, 
30:20:2; 200 mL each); volumes of collected fractions: 15 mL; sorbent: 50 g 
Column 5 eluent: cyclohexane–CHCl3–Me2CO (15:10:0.5, 10:20:2, 10:20:3, 5:20:5; 70 ml 
each); volumes of collected fractions: 5 mL; sorbent: 25 g 
Column 6 eluent: cyclohexane–EtOAc–EtOH (60:10:0, 30:10:0, 30:10:1, 30:20:1; 120 mL 
each); volumes of collected fractions: 10 mL; sorbent: 40 g 
Column 7 eluent: EtOAc–EtOH–H2O (32:2:0, 32:2:1, 32:2:1.5, 32:4:1.5, 32:4:2, 32:8:4, 
32:16:8, 32:32:16; 1500 mL each); volumes of collected fractions: 100 mL; 
sorbent: 330 g 
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➢ Fractionation by VLC on reversed-phase silica gel 
Column 8 eluent: MeOH–H2O (6:4, 7:3, 8:2, 10:2, 10:1; 100 mL each); volumes of 
collected fractions: 10 mL; sorbent: 23 g 
Column 9 eluent: MeOH–H2O (5:5, 6:4, 7:3, 8:2, 9:1; 200 mL each); volumes of collected 
fractions: 15 mL; sorbent: 54 g 
Preparative layer chromatography: PLC was carried out on 10 x 20 cm plates coated with NP and RP 
silica gel (TLC Silica gel 60 F254, and TLC Silica gel 60 RP-18 F254S, Merck). Separation was accomplished 
by developing the plates in glass chambers previously saturated with mobile phase vapor for 10 
minutes. The chromatograms were visualized by: 
• UV-light: the TLC plates were exposed to UV light at 254 nm 
• cc. H2SO4: after spraying cc. H2SO4 at the right borders, TLC plates were heated at 110 ˚C for 2 
minutes 
The purified compounds were eluted from the scraped adsorbent with CHCl3. 
➢ Purification by PLC on normal phase silica gel 
Mobile phase 1: toluene–Me2CO (10:2); mobile phase 2: toluene–Me2CO (8:2); mobile phase 
3: cyclohexane–CHCl3–MeOH (15:10:1); mobile phase 4: cyclohexane–EtOAc–EtOH (25:15:1); 
mobile phase 5: EtOAc–HCOOH–H2O (85:10:5) 
➢ Purification by PLC on reversed-phase silica gel 
Mobile phase 6: MeOH–H2O (11:2); mobile phase 7: MeCN–H2O (11:1); mobile phase 8: 
MeOH–H2O (10:1); mobile phase 9: MeCN–H2O (3:1) 
HPLC: separations by HPLC were performed on pre-packed Hibar RT LiChrospher Si 100 and 
LiChrospher RP-18 columns (250 x 4 mm, 5 μm, Merck), using a Waters Millipore instrument consisted 
of a Controller 600, a Pump 600, a Photodiode Array Detector 2998, an In-Line Degasser AF, and an 
Injector Rheodyne 7725i. Chromatographic separations were monitored at 254 and 366 nm. The 
samples were filtered through PTFE-L syringe filters (pore size 0.45 μm, FilterBio) before injection. 
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➢ Purification by NP-HPLC 
Method 1  eluent: cyclohexane–EtOAc–EtOH (90:15:0.2); flow rate: 0.6 mL/min 
Method 2  eluent: cyclohexane–EtOAc–EtOH (25:15:1); flow rate: 1.5 mL/min 
Method 3  eluent: cyclohexane–EtOAc–EtOH (50:10:1); flow rate: 1.5 mL/min 
Method 4  eluent: cyclohexane–EtOAc–EtOH (30:10:1); flow rate: 1.5 mL/min 
➢ Purification by RP-HPLC 
Method 5  eluent: MeCN–H2O (7:3); flow rate: 1.5 mL/min 
Method 6  eluent: MeCN–H2O (6:4); flow rate: 1.5 mL/min 
Method 7  eluent: MeCN–H2O (1:1); flow rate: 1.5 mL/min 
Method 8  eluent: MeOH–H2O–THF (10:3:7); flow rate: 0.5 mL/min 
Method 9  eluent: MeCN–H2O–HCOOH (30:70:1); flow rate: 0.5 mL/min 
The collected fractions were concentrated in vacuo under 40 ˚C. The diterpenoids were kept in dark 
vials in a refrigerator. The purity of the obtained compounds was checked by TLC and HPLC methods 
prior to submitting them to pharmacological investigations. 
 
3.3.3. Preparation of plant extracts for pharmacological screening 
For pharmacological investigations, 50 g fresh plant material of E. davidii was extracted with MeOH 
(500 mL) in an ultrasonic bath. After filtration, the extract was evaporated to dryness under reduced 
pressure. The obtained viscous residue was dissolved in 50% aqueous MeOH (50 mL) and was then 
subjected to solvent-solvent partition with n-hexane, CHCl3, and EtOAc (each 3 x 50 mL). In the next 
step, the dried plant material was subsequently extracted with boiling H2O (400 mL, 15 min). The 
organic phases were concentrated under vacuum, while the aqueous portions were freeze-dried. 
 
3.4. Characterization and structure determination of the isolated compounds 
Mass spectroscopy: High-resolution MS data were recorded on a Thermo Q Exactive Plus Orbitrap mass 
spectrometer equipped with an ESI electrospray source and coupled with an Agilent 1100 HPLC system. 
The samples were measured with flow injection analysis method. The mass spectrometer was working 
in positive mode, and the scan mass range was set to m/z 150–2000 at a resolution of 140000. The 
data were acquired and processed with Thermo Xcalibur 4.0 software. 
Nuclear magnetic resonance spectroscopy: NMR spectra were recorded in CDCl3, CD3OD, and C5D5N on 
a Bruker Avance DRX 500 spectrometer at 500 MHz (1H) and 125 MHz (13C). The signals of the residual 
solvents (δH 7.26, 3.31, and 8.74 ppm; δC 77.16, 49.00, and 150.35 ppm, respectively) were taken as 
reference points. Chemical shifts are expressed in parts per million (ppm) and coupling constant (J) 
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values in Hz. The 2D data were acquired and processed with MestReNova v6.0.2-5475 and TopSpin 
3.5pl7 softwares. 
Ultraviolet spectroscopy: UV spectra were measured in MeOH by a Shimadzu UV-2101 spectrometer. 
X-ray crystallographic study: Intensity data of 1 was collected at synchrotron SOLEIL at the PROXIMA 1 
beamline (macromolecular crystallography beamline, λ = 0.79990 Å, beam size HxV = 40 x 30 µm2) at 
100(2) K in the range of 1.682 ° ≤ θ ≤ 31.198 °. The structure was solved by direct methods and refined 
by full-matrix least squares. 
Melting point: Melting point of compound 1 was determined by a Linkam hot stage microscope 
(temperature range of –180–400 °C). Melting points of the rest of the diterpenoids are uncorrected. 
Optical rotation: Optical rotations were measured in CHCl3 by using a Perkin Elmer 341 polarimeter. 
 
4. Results 
4.1. Screening of E. dulcis, E. taurinenis, and E. davidii for diterpenoid contents 
The extractions and preparations of the samples were carried out as described in section 3.2. 
Concerning the screening results of E. dulcis and E. taurinensis, TLC chromatograms of fractions eluted 
with 60% aqueous MeOH exhibited dense brown and black spots attributable to diterpenoid esters (Rf 
values: 0.15–0.70). TLC monitoring of fractions obtained with MeOH–H2O (4:1) revealed purple spots 
on the plates with higher Rf values (0.75–0.95), which indicated the predominant presence of 
triterpenes and fats. The aforementioned observations suggested that the apolar extracts of E. dulcis 
and E. taurinensis contain a series of different diterpenoids. In case of E. davidii, the lack of 
characteristic brown and black spots of diterpenoids implied that these secondary metabolites are 
absent or present in very low concentrations in the plant. 
 
4.2. Isolation procedures 
4.2.1. Isolation of diterpenoids from E. dulcis 
Since diterpenoids have been reported from different organs of Euphorbia species, the whole plants 
of E. dulcis were collected. Post-mortem enzymatic activity was stopped by freezing the harvested 
fresh plants. The frozen plant material was crushed and exhaustively percolated with MeOH at room 
temperature. The crude extract was concentrated under reduced pressure, resuspended in H2O, and 
subjected to solvent-solvent partitioning with CHCl3. Upon evaporation of the solvent, the organic 
phase yielded a dark green oily residue (33.6 g), which was chromatographed on a polyamide column 
with mixtures of MeOH–H2O (Figure 6). The TLC analysis showed that the diterpenoids accumulated in 
the fraction eluted with MeOH–H2O (3:2). The MeOH–H2O (4:1) eluate contained mainly chlorophyll, 
triterpenes, and fats, and was not investigated further. 
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The diterpene-rich extract (5.90 g) was separated on VLC column 1 using gradient mixtures of 
cyclohexane–EtOAc–EtOH to afford 55 fractions (A1-55). Combined fractions A21-32 were submitted 
to VLC column 8 and eluted with decreasingly polar mixtures of MeOH–H2O to yield 45 subfractions 
(B1-45). Purification of subfraction B20 by RP-HPLC method 5 furnished EUD-6 (11) (tR: 6.8 min, 23.1 
mg) and EUD-4 (2) (tR: 8.5 min, 83.0 mg). Pooled subfractions B21-25 were chromatographed under 
the same conditions to provide EUD-8 (1) (tR: 11.5 min, 177.4 mg) and an additional portion of EUD-4 
(2) (35.3 mg). Further separation of subfractions B29-36 was carried out on silica gel with mobile phase 
1 to give EUD-19 (3) (9.4 mg). Subfractions B49-56 were sequentially purified by PLC over NP- and RP 
silica gel, using corresponding mobile phases 2 and 6, to isolate EUD-16 (4) (3.2 mg) and EUD-10 (5) 
(5.1 mg). 
Combined fractions A38-47 were loaded onto VLC column 9 and was eluted with a gradient of MeOH–
H2O to collect 62 subfractions (C1-62). Subfractions C32-42 were fractionated on VLC column 2 by 
toluene–CHCl3–Me2CO mixtures to yield 27 subfractions (D1-27). The eluates D6-7 and D8-10 were 
subjected to RP-HPLC method 6 to obtain EUD-2 (10) (tR: 7.2 min, 8.2 mg) and EUD-3 (9) (tR: 8.6 min, 
8.0 mg). Consecutive purification of subfractions D11-24 first by PLC with the use of mobile phase 3, 
and finally by RP-HPLC method 7 led to the isolation of pure compounds EUD-22 (8) (tR: 9.2 min, 8.5 
mg), EUD-21 (7) (tR: 12.5 min, 16.8 mg), and EUD-23 (6) (tR: 17.4 min, 22.1 mg). 
 
Figure 6. Isolation of diterpenoids from Euphorbia dulcis 
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Figure 7. Isolation of diterpenoids from Euphorbia taurinensis 
 
4.2.2. Isolation of diterpenoids from E. taurinensis 
The fresh whole plants of E. taurinensis were grinded and percolated with MeOH at room temperature. 
After concentration in vacuo, the crude extract was diluted with H2O and partitioned with CHCl3. The 
organic phase on evaporation to dryness left a syrupy residue (16.65 g), which was separated by 
polyamide OCC with mixtures of MeOH–H2O (Figure 7). Visualization of the collected fractions 
demonstrated that the diterpenoids occurred in both of the 60% and 80% MeOH fractions. 
The fraction obtained with MeOH–H2O (3:2) was transferred onto silica gel vacuum column 4 and 
eluted in a gradient manner with cyclohexane–EtOAc–EtOH to collect 80 fractions (B1-80). Pooled 
fractions B38-49 were first subjected to NP-HPLC (method 3), then the compound observed at 
retention time of 6.2 min was rechromatographed on silica gel plates using mobile phase 4 to furnish 
ETA-8 (12) (12.9 mg). Combined fractions B50-69 were successfully separated on VLC column 5 with a 
gradient solvent system composed of cyclohexane–CHCl3–Me2CO to yield 51 subfractions (C1-51). C7 
was further purified by PLC (mobile phase 9) to afford ETA-9 (14) (12.1 mg). 
The 80% methanolic extract was initially fractionated on VLC column 3 by eluting with a stepwise 
gradient of cyclohexane–EtOAc–EtOH to collect 70 fractions (A1-70). Fractions A20-30 were developed 
on silica gel plates with mobile phase 7, and at the next step the proper separation of ETA-5 (15) (tR: 
5.3 min, 5.4 mg), ETA-1 (16) (tR: 6.7 min, 1.8 mg), and ETA-2 (17) (tR: 7.4 min, 5.1 mg) was performed 
by HPLC method 1. Combined fractions A31-35 were repeatedly chromatographed on silica gel plates 
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with mobile phase 4 and by RP-HPLC method 6 to obtain ETA-6 (13) (tR: 5.5 min, 1.7 mg). Final 
purification of the main diterpenoid constituent of fractions A43-50, ETA-7 (18) (tR: 7.1 min, 2.1 mg) 
was achieved by PLC (mobile phase 8) and NP-HPLC (method 2). 
 
4.2.3. Isolation of diterpenoids from E. guyoniana 
The dried aerial parts of E. guyoniana (45 g) were powdered and thoroughly extracted with CHCl3 in an 
ultrasonic bath at room temperature. The crude extract was concentrated in vacuo to give a brown 
viscous residue (1.15 g). Rough fractionation of the lipophilic phase was performed by polyamide OCC 
using MeOH–H2O mixtures as mobile phase (Figure 8). The TLC investigation showed that diterpenoids 
were present only in the 60% methanolic extract, which was further fractionated on NP-VLC column 6 
by eluting with a gradient of cyclohexane–EtOAc–EtOH to collect 46 fractions. Purification of combined 
fractions 17-21 by chromatographic techniques of NP-HPLC method 4 and RP-HPLC method 8 furnished 
EGU-4 (19) (3.0 mg), detected at 4.2 min and 7.1 min retention times, respectively. By using the same 
HPLC methods, combined fractions 22-26 gave EGU-3 (20) (3.3 mg), observed at respective retention 
times 5.4 min and 5.7 min. 
 
Figure 8. Isolation of diterpenoids from Euphorbia guyoniana 
 
4.2.4. Isolation of flavonoids from E. davidii 
The frozen plant material was grinded, percolated with MeOH at room temperature, then the solvent 
was evaporated under reduced pressure. The crude extract (182.55 g) was resuspended in H2O and 
subjected to a repetitive liquid-liquid extraction using CHCl3 and EtOAc (Figure 9). The latter phase was 
separated over VLC column 7 by eluting with mixtures of EtOAc–EtOH–H2O. 120 fractions were 
collected, from which fraction 4, 5, and 6 with high content of flavonoids were further separated by 
PLC using mobile phase 5, and then by RP-HPLC method 9. The peaks collected at 5.3, 6.2, and 7.3 min 
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retention times afforded EDI-17 (21) (3.0 mg), EDI-18 (22) (3.0 mg), and EDI-19 (23) (3.0 mg), 
respectively. 
 
Figure 9. Isolation of flavonoid glycosides from Euphorbia davidii 
 
4.3. Structure determination of the isolated compounds 
EUD-8 (1) 
The molecular formula of EUD-8 (1) was assigned as C36H48O9 by the peak of the protonated molecule 
at m/z 625.3371 [M + H]+ (calcd 625.3377; HRESIMS data of the novel compounds isolated from 
E. dulcis, E. taurinensis, and E. guyoniana are summarized in Annex 1). Its 1H and JMOD NMR spectra 
displayed characteristic signals of a benzoyl (δH 7.98 d, 7.49 t, 7.38 t; δC 165.8, 132.8, 130.4, 130.0, 
128.5), two acetyl (δH 2.19 s, 1,86 s; δC 171.4, 169.5, 2 x 21.2), and a tigloyl group (δH 6.50 q, 1.28 d, 
1.23 s; δC 166.6, 137.8, 128.1, 14.3, 11.4; for comprehensive 1D NMR data of 1–9, see Annexes 2 and 
3). Besides the ester functionalities, the JMOD spectrum contained the resonances of 20 carbons 
attributable to a diterpene core. The HSQC spectrum showed that the skeleton of 1 comprises five 
methyls, two methylenes, seven methines (including four oxymethines), and three olefinic carbons. 
The resonances at δC 135.1, 84.0, and 40.2 that did not exhibit any correlations were classified as a 
nonprotonated sp2, an oxygenated tertiary, and a quaternary carbon, respectively. The 1H-1H COSY and 
HSQC spectra suggested the presence of a disubstituted (δH 5.65 dd, 5.11 d; δC 129.6, 138.3) and a 
trisubstituted (δH 5.69 d; δC 119.8, 135.1) olefinic bond in the diterpenoid scaffold. Apart from the 
benzoyl and tigloyl groups, COSY cross-peaks revealed three further sequences of correlated protons: 
–CH2–CH(CH3)–CH(OR)–CH–CH= (δH 2.04 m, 1.74 m, 2.11 m, 0.90 d, 5.38 br s, 2.89 dd, 5.69 d) [A],  
–CH(OR)–CH2–CH(OR)– (δH 5.08 br s, 1.99 m, 4.86 br s) [B], and –CH=CH–CH(CH3)–CH(OR)– (δH 5.11 d, 
5.65 dd, 2.56 m, 0.94 d, 4.91 d) [C]. In addition, a weak 4JH-H (W-type) correlation between the protons 
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resonating at δH 5.69 and 1.75 indicated their close proximity.184 According to the molecular formula, 
a bicyclic ring system was proposed for compound 1 in order to satisfy the 13 indices of hydrogen 
deficiency. Connectivities of partial structures were determined by means of an HMBC experiment. 
The two- and three-bond correlations of H-1a/b, H-3, and H-4 with C-15 (δC 84.0), together with H-
14/C-1 proved that segment A forms a methyl-substituted cyclopentane moiety present in many types 
of Euphorbiaceae diterpenoids.30 The cross-peaks of H3-17 with C-5, C-6 (δC 135.1), and C-7, as well as 
between H-9, H-12, H3-18, H3-19, and C-10 (δC 40.2) demonstrated that subunits A-C and two geminal 
methyls are involved in the formation of a 12-membered macrocycle characteristic of a jatrophane 
diterpenoid core. In view of the aforementioned HMBC interactions of the deshielded H3-17 (δH 1.75) 
and the lack of exomethylene signals, it was concluded that compound 1 contains a rare Δ(5,6) olefinic 
bond instead of the regular Δ(6,17) double bond. The locations of the ester substituents were 
determined by the correlations of skeletal oxymethines H-3, H-7, H-9, and H-14 with carbonyl carbons 
at δC 165.8 (benzoyl), 166.6 (tigloyl), 169.5, and 171.4 (acetyls), respectively. Although we did not 
observe any exhangeable proton signal in the 1H NMR spectrum, the molecular formula and C15 at 
84.0 clearly required the presence of a hydroxy group at C-15. 
The relative configuration of compound 1 was assessed by analysing the NOESY spectrum and the 
pattern of coupling constants. A set of NOE cross-peaks of the frequently chosen reference H-4α with 
H-2, H-3, H-13, and H-14 dictated the β-orientation of the secondary methyls H3-16 and H3-20, the C-3 
benzoyl, and the C-14 acetyl groups.185 The C-1 geminal protons were distinguished via the H-1α/H-14 
and H-1β/H3-16 NOE correlations. The large coupling constant between H-4 and H-5 (3JH4-5 = 10.4 Hz) 
suggested their location on the opposite sides of the molecule.127 With regard to the diagnostic NOE 
signals H-4/H3-17 and H-5/H-9, as well as the absence of an H-5/H3-17 correlation, the trisubstituted 
Δ(5,6) olefinic bond must have an E-configuration.24,185 The E stereochemistry of the Δ(11,12) double bond 
was evident from the large value of 3JH11-12 (15.8 Hz). This finding was further corroborated by NOE 
cross-peaks of H-11 with H-13 and H3-19, and of H-12 with H3-18.24,106 The strong NOEs between H-
7/H3-17, H-5/H-9, and H-9/H3-18 confirmed the β-orientation of the C-7 tigloyl and the α-position of 
the C-9 acetyl groups, respectively.114,184 H3-20 was presumed to occupy an equatorial-like position 
from its NOEs with H-14, and from the missing H-11/H3-20 interaction.127,186 The C-15 hydroxy group 
was assigned as β-oriented based on the fact that all of the jatrophane diterpenoids isolated to date 
contain a trans-fused bicyclo[10.3.0]pentadecane ring system.113 The rather sharp proton and carbon 
signals indicated that molecules with endo- and exo-conformations were undergoing fast 
interconversions and rapid equilibrium in solution.83,127 Considering the large value of 3JH4-5, the NOE 
correlation between H-4 and H3-17, and the restricted rotation around the C-5/C-6 axis, it was certain 
that the H3-17 methyl is predominantly orthogonal to the mean plane of the macrocycle, implying that 
compound 1 preferentially adopted an endo-type conformation.83 
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 R1 R2 R3 R4 R5 
1 (EUD-8) Tig H Ac Ac H 
2 (EUD-4) Tig OAc Ac Ac H 
3 (EUD-19) Tig OAc Ac Tig H 
4 (EUD-16) H OAc Ac Tig H 
5 (EUD-10) H OAc Ac Ac H 
6 (EUD-23) Ac OH Ac Ac H 
7 (EUD-21) Ac OH H Ac H 
8 (EUD-22) H OH H Ac H 
9 (EUD-3) Ac OAc Ac H Ac 
10 (EUD-2) Ac OAc Ac Ac H 
11 (EUD-6) Ac H Ac Ac H 
 
The absolute configuration of compound 1 was determined by single-crystal X-ray diffraction. A 
minuscule crystal with the size of 0.02 x 0.02 x 0.15 mm was mounted on a Kapton loop (for details of 
the crystallization procedure and the crystalline structure of 1, see Appendix I). Compound 1 
crystallized in the monoclinic chiral space group P21 with three crystallographically independent but 
chemically identical conformers in the asymmetric unit (Figure 10A). The conformational differences 
of the core are negligible despite the flexible 12-membered macrocycle, only the atomic positions at 
the terminal part of ester functions differ. The absolute configuration has been established in the 
diffraction measurement based on the anomalous dispersion effect of the nine oxygen atoms present 
in the diterpenoid. For all three conformers of 1, the assignment is most likely 
(2S,3S,4S,7R,9R,13S,14S,15R)-9α,14β-diacetoxy-3β-benzoyloxy-15β-hydroxy-7β-tigloyloxyjatropha-
5E,11E-diene (Figure 10B). As demonstrated by the NOESY and X-ray diffraction experiments, the 
conformers of compound 1 in the crystal state were in good agreement with the dominant conformer 
presents in solution. 
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 A B 
Figure 10. Panel A: Molecular overlay of the three conformers in the asymmetric unit. 
Panel B: Molecular structure of compound 1 with atomic labelling. 
The displacement ellipsoids are drawn at the 50% probability level. 
 
EUD-4 (2) 
The molecular formula of EUD-4 (2) was determined to be C38H50O11 by the HRESIMS ion at m/z 
705.3281 [M + Na]+ (calcd 705.3251). Comparison of the NMR spectroscopic data of 1 and 2 indicated 
that the structures of these diterpenoids differ only in an acetoxy group. This conclusion was based on 
the presence of the additional oxymethine signal at δH 5.14 and methyl resonance at δH 2.04, which 
gave HMBC correlations with a carbonyl carbon at δC 172.0. The 1H-1H COSY spectrum defined subunit 
B as –CH(OR)–CH(OR)–CH(OR)– (δH 5.08 br s, 5.14 br s, 5.31 br s). HMBC cross-peaks of H-7/C-8, H-8/C-
9, and H-8/C-10 further confirmed that the above-mentioned acetoxy moiety is attached to C-8. 
Interestingly, the hydrogen signals of segment B appeared as broad singlets. The small or even zero 
3JH7-8 and 3JH8-9 coupling constants are characteristic of the 7,8,9-trisubstituted jatrophanes, and can be 
explained by the nearly 90˚ dihedral angles between H-7/H-8 and H-8/H-9.79,185 The key heteronuclear 
correlations depicted in Figure 11 established the connectivities of spin systems A-C through 
nonprotonated carbons at δC 132.2 (C-6), 84.3 (C-15), and 41.0 (C-10), and the locations of the 
esterifying groups on the diterpenoid core. The β-orientation of 8-OAc was shown by NOEs of H-8 with 
H3-17 and H3-19,24,129 while the other eight asymmetric carbons were found to be identical with those 
of compound 1.  
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Figure 11. Relevant 2D correlations of compound 2. Bold bonds indicate COSY interactions 
between adjacent skeletal protons, while arrows (C → H) illustrate HMBC cross-peaks. 
 
EUD-19 (3) 
EUD-19 (3) has the molecular formula C41H54O11 compatible with its sodiated HRESIMS ion at m/z 
745.3596 [M + Na]+ (calcd 745.3564). Preliminary investigation of the 1H and JMOD spectra indicated 
the presence of a jatrophane parent system esterified with a benzoic, two acetic, and two tiglic acids. 
The HMBC cross-peaks of H-3, H-7, H-8, H-9, and H-14 with carbonyl signals at δC 167.4 (benzoyl), 168.2 
(tigloyl), 172.1, 171.6 (acetyls), and 170.0 (tigloyl), respectively, revealed the location of ester groups 
on the highly oxygenated terpenoid core. The proton resonances of 7-O-Tig (δH 6.57 q, 1.30 br d, 1.25 
s) were significantly shielded compared to those of 14-O-Tig (δH 7.07 dq, 1.92 br s, 1.87 d), which was 
caused by the anisotropic effect of the cis-located C-3 aromatic substituent.187 NOEs permitted 
assignment of the same relative configurations of the stereogenic carbons as in compounds 1 and 2. 
 
EUD-16 (4) 
The molecular formula of EUD-16 (4) was determined to be C36H48O10 in accordance with its HRESIMS 
sodium adduct ion at m/z 663.3172 [M + Na]+ (calcd 663.3145). The 1H NMR spectrum contained the 
signals of a benzoyl, two acetyls, and a tigloyl group. The lack of diamagnetic shifted signals attributed 
to 7-O-Tig and a hydrogen resonance at δH 3.78 with no HSQC cross-peak demonstrated that the 
difference between 4 and 3 was restricted to the absence of an acyl residue at C-7. This hydroxy group 
was involved in the formation of subunit B as follows: –CH(OH)–CH(OR)–CH(OR)– (δH 3.99 d, 3.78 br s, 
5.15 d, 4.54 d), and was assigned as β-oriented based on the strong 7-OH/H-9, H-7/H-8, and H-7/H3-17 
NOE interactions. 
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EUD-10 (5) 
HRESIMS suggested the molecular formula C33H44O10 for EUD-10 (5) via the sodium adduct ion at m/z 
623.2858 [M + Na]+ (calcd 623.2832). The 1D NMR spectra displayed signals of a benzoyl and three 
acetyl groups. The proton and carbon chemical shifts of structural segments A-C were virtually the 
same as those of compound 4. The HMBC correlations of skeletal oxymethines H-3, H-8, H-9, and H-14 
with ester carbonyls at δC 166.7 (benzoyl), 169.9, 172.2, and 171.2 (acetyls) provided key information 
regarding the locations of substituents on the diterpenoid backbone. Thus, compound 5 was assignable 
as the 14-O-acetyl analogue of 4.  
 
EUD-23 (6) 
The sodiated ion at m/z 623.2816 [M + Na]+ (calcd 623.2832) showed that compound 6 has the same 
molecular formula as 5. Taking into account the 1D NMR signals of one benzoyl and three acetyl 
groups, it was assumed that 6 is an isomer of 5. Because of the heavily overlapping hydrogen signals 
in CD3OD or CDCl3, pyridine-d5 was chosen as solvent for the 2D NMR measurements. Although the 
chemical shifts of 5 and 6 were not directly comparable, differences in subunits B of the two 
compounds [–CH(OR)–CH(OH)–CH(OR)– (δH 5.51 br s, 4.28 d, –OH 5.70 d, 5.63 br s) in 6 and  
–CH(OH)–CH(OR)–CH(OR)– in 5] were quickly revealed by the COSY spectra. The HMBC cross-peaks of 
H-3, H-7, H-9, and H-14 with carbonyl carbons at δC 166.1 (benzoyl), 170.0, 169.6, and 171.8 (acetyls) 
placed the ester functions at C-3, C-7, C-9, and C-14. The location of 7-OAc in the shielding cone of C-
3 cis-benzoyl group was demonstrated by its upfield shifted methyl protons (δH 1.32 vs. δH 2.13 – 9-
OAc, and 2.12 – 14-OAc).185  
 
EUD-21 (7) 
The HRESIMS ion at m/z 581.2732 [M + Na]+ (calcd 581.2727) provided the molecular formula C31H42O9 
for EUD-21 (7), which could be derived from 6 by the loss of an acetyl unit. The 1D NMR spectra 
supported this deduction, as it displayed proton and carbon resonances ascribable to a benzoyl and 
two acetyl functions. As explained above, the diamagnetic shifted acetyl at δH 1.25 has to be attached 
to C-7. Mutual 1H-1H COSY couplings between hydroxy groups (δH 4.12 br s, 2.70 d) and neighbouring 
oxymethines H-8 and H-9 established substructure B with a vicinal diol moiety  
[–CH(OR)–CH(OH)–CH(OH)–]. The long-range HMBC interactions of H-3, H-7, and H-14 with carbonyl 
signals at δC 165.6, 172.5, and 171.3 determined the positions of benzoyloxy and acetoxy groups at the 
corresponding carbons C-3, C-7, and C-14.  
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EUD-22 (8) 
The molecular formula C29H40O8 was assigned to EUD-22 (8) with respect to its sodium adduct ion [M + 
Na]+ observed at m/z 539.2644 (calcd 539.2621). Its 1D NMR spectra exhibited the signals of a benzoyl 
and an acetyl group. Considering the HMBC cross peak of H-14 with a carbonyl carbon at δC 171.3, the 
latter function was placed onto C-14.  
 
EUD-3 (9) 
The sodium adduct ion detected at m/z 665.2960 [M + Na]+ (calcd 665.2938) in the HRESIMS data of 
EUD-3 (9) suggested the molecular formula C35H46O11. Initial analysis of the 1H, JMOD, and HSQC 
spectra showed substantial differences between compounds 9 and 1–8, namely, the remarkable 
paramagnetic shifts of C-1 geminal protons (δH 2.95 br d, 2.14 m), the acetyl resonance at δH 2.41, and 
the oxygenated tertiary C-15 at δC 94.8. In order to elucidate the structure of compound 9, a complete 
series of 2D NMR spectra were recorded and analysed. It was found that 9 is a structural isomer of the 
known euphomelliferene B, in which the ester and hydroxy substituents at C-14 and C-15 were 
interchanged. This unusual feature was confirmed by a COSY cross-peak between H-14 (δH 3.54) and a 
hydroxy signal (δH 4.93) and by the absence of three-bond HMBC correlations of the acetyl carbonyl 
carbon at δC 174.3 with protons of the diterpenoid core. The correlations of oxymethines H-3, H-7, H-
8, and H-9 with related carbonyl carbons at δC 164.9 (benzoyl), 168.9, 170.2, and 169.2 (acetyls) located 
the four other esters at C-3, C-7, C-8, and C-9, respectively. A set of NOEs in conjunction with the 
missing interaction between H-4α and 15-OAc revealed the same relative configurations of stereogenic 
carbons as determined above for compounds 1–8.184  
 
EUD-2 (10) and EUD-6 (11) 
According to the literature data, EUD-2 (10) and EUD-6 (11) were identified as euphomelliferene B and 
euphornin, respectively.185,187  
 
ETA-8 (12) 
The HRESIMS ion at m/z 679.2729 [M + Na]+ (calcd 679.2731) provided the molecular formula C35H44O12 
for ETA-8 (12). The 1H and JMOD spectra contained the signals of a benzoyl (δH 7.84 d, 7.58 t, 7.46 t; δC 
166.0, 133.5, 129.6, 129.4, and 128.9) and three acetyl groups (δH 2.15 s, 2.08 s, 2.07 s; δC 170.9, 170.5, 
170.2, 21.9, 21.2, and 20.6) (for comprehensive 1D NMR data of 12, see Annex 4). The presence of an 
acetoxyacetate group was verified by HMBC correlations between an isolated oxymethylene (δH 4.58 
d, 4.48 d) and two ester carbonyl carbons at δC 167.0 and 170.2. Apart from the ester residues, 20 
resonances in the JMOD spectrum were classified on the basis of their HSQC cross-peaks and chemical 
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shifts as four methyls, four methylenes, seven methines (including three oxymethines), and five 
nonprotonated carbons. The latter signals were assigned as a keto (δC 220.1), two oxygenated tertiary 
(δC 83.1, 82.4), and two quaternary (δC 45.8, 41.3) carbons, respectively. Taking into account the 
benzene ring and the six carbonyls of the molecule, a tetracyclic diterpenoid core was proposed for 12 
in order to satisfy the 14 indices of hydrogen deficiency. The 1H-1H COSY spectrum defined two 
sequences of adjacent protons as –CH2–CH(CH3)–CH(OR)–CH–CH(OR)– (δH 2.37 dd, 1.54 dd, 2.07 m, 
0.93 d, 5.79 br s, 3.28 dd, 5.29 d) [A], –CH2–CH–CH–CH2– (δH 2.57 br d, 1.28 t, 3.64 ddd, 1.50 dd, 1.92 
br d, 1.85 dd) [B], and a geminal proton pair (δH 3.54 d, 1.05 d) [C] (Figure 12A). The HMBC correlations 
from H-1b, H-3, H-5, H-14, and 15-OH to C-15 (δC 83.1) suggested that subunit A forms a cyclopentane 
ring substituted with a methyl, a hydroxy, and an ester group. The long-range interactions between H-
5, H-7a/b, H-17a/b, and C-6 (δC 82.4), as well as between H-11a, H-12, H-14, H-17a/b, H3-20, and C-13 
(δC 41.3) indicated that spin systems A–C and the oxymethine H-14 are incorporated into a 
bicyclo[4.3.1]decane ring system.157 The HMBC cross-peaks of H-11a/b, H3-18, and H3-19 with C-10 (δC 
45.8), and of H-7b, H-8, H-11b, H-12, H3-18, and H3-19 with C-9 (δC 220.1) showed that the fourth ring 
of the terpenoid skeleton is composed of subunit B, a quaternary carbon attached to the gem-methyls, 
and a keto group. The locations of ester moieties were determined by the heteronuclear correlations 
of H-3, H-5, and H-14 with carbonyl carbons at δC 166.0 (benzoyl), 167.0 (acetoxyacetyl), and 170.5 
(acetyl). In addition, a weak four-bond HMBC correlation of the acetyl methyl at δH 2.07 with C-6 
established its position. 
   
 A B 
Figure 12. Panel A: Key 2D correlations of 12. Bold bonds indicate COSY interactions between 
nearby skeletal protons, while arrows (C → H) highlight important HMBC cross-peaks. 
Panel B: Calculated molecular structure of 12. 
 
The relative configurations of the asymmetric carbons were elucidated by means of a NOESY 
experiment. H-4 at the junction of rings was chosen as the initial α reference point. The cross-peaks of 
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H-4 with H-2 and H-3, and of the aromatic protons H-3’/H-7’ with 15-OH showed the β-orientation of 
the H3-16 methyl and C-3 benzoyl groups. A further correlation of H-4 with H-17a indicated the 
α-orientation of the C-17 bridge.155 The NOE correlations of H-5 with H-7β, H-8, and 15-OH led to the 
assignment of the C-5 acetoxyacetyl unit as α, while the 15-OH/H-1β, H-14/H-1α, and H-14/H3-20 
correlations confirmed that the C-14 acetyl moiety occupied a β-position.157 The large coupling 
constant between H-8 and H-12 (3JH-H = 15.1 Hz) demonstrated their rigid antiperiplanar relationship.118 
The C-11 geminal protons were readily distinguished by NOEs between H-11β /H3-19, H-11α /H3-18, 
and H-12/H3-18. The above findings were in great agreement with a minimum energy conformation 
generated by molecular dinamics calculations using the MM2 force field method (Figure 12B). 
 
 
ETA-6 (13) 
The molecular formula C33H42O8 of ETA-6 (13) was compatible with the HRESIMS ion at 589.2773 [ M + 
Na]+ (calcd 589.2777). Comparison of its 1D NMR data with those of the known jatrophane diterpenoid 
15 (see later) revealed only minor differences between them, including the absent resonances of a 
cinnamoyl group, the presence of two acetyl singlets at δH 2.05 and 1.93, and the slightly downfield 
shifted H-9 (δH 4.36 d vs. 4.51 d in 15) (for comprehensive 1D NMR data of 13, see Annex 4). These 
observations, together with the HMBC cross-peaks of H-9 and an acetyl methyl with a carbonyl carbon 
at δC 170.9 suggested that compound 13 bears an acetyl function at C-9 instead of a cinnamate. The 
relative configuration was determined through NOE cross-peaks between H-2/H-3, H-3/H-4, H-4/H-13, 
H-11/H-13, H-5/15-OH, H-9/H-12, H-9/H3-19, and H-12/H3-20. The NOE correlation of H-5 with H-17a 
and the large 3JH4-5 coupling constant (10.1 Hz) indicated that the exomethylene is perpendicular to the 
mean plane of the macrocycle, thus 13 favoured an endo-type conformation.83,188 
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ETA-9 (14) 
The structure of ETA-9 (compound 14) was determined by 1D and 2D NMR spectroscopy, and it was 
found to be paralinone A, which is a known metabolite of E. segetalis and E. paralias.118,155 
 
ETA-5 (15) 
ETA-5 (15) was identified as 5-acetoxy-3,9-dicinnamoyloxy-15-hydroxy-14-oxojatropha-6(17),11E-
diene, which was isolated from Euphorbia segetalis prior to our work.118  
 
ETA-1 (16), ETA-2 (17), and ETA-7 (18) 
The structures of ETA-1, ETA-2, and ETA-7 (16–18, respectively) were solved by 1D and 2D NMR 
measurements. Comparison of the proposed structures with literature data allowed the assignment 
of these diterpenoids as 3-O-angeloyl-20-deoxyingenol (16),189 3-O-angeloyl-17-angeloyloxy-20-
deoxyingenol (17),156 and 20-O-acetyl-3-O-angeloyl-17-angeloyloxyingenol (18).118  
 
EGU-4 (19) 
The molecular formula C39H52O13 of (19, guyonianin G) was confirmed by the HRESIMS sodium adduct 
ion at m/z 751.3338 [M + Na]+ (calcd 751.3306). According to the 1H and JMOD spectra, the core of the 
molecule was pentaesterified with a benzoic acid (δH 7.99 d, 7.57 t, 7.42 t; δC 165.2, 133.8, 130.2, 129.5, 
and 128.8), two acetic acids (δH 2.06 s, 2.03 s; δC 170.4, 169.4, 21.4, and 20.9), and two isobutyric acids 
(δH 2.70 sept, 2 x 1.36 d; δC 176.0, 35.6, 19.3, 19.2, and δH 1.84 sept, 0.87 d, 0.51 d; δC 175.1, 33.7, 19.1, 
17.7) (for comprehensive 1D NMR data of 19 and 20, see Annex 4). Not counting the esters, the 20 
further signals displayed in the JMOD spectrum were categorized as four methyls, a methylene, an 
exo-methylene, seven methines (including five oxymethines), and two olefinic carbons. In addition, the 
five resonances of nonprotonated carbons were labelled as one keto (δC 212.4), one olefinic (δC 144.5), 
two oxygen-attached (δC 89.6 and 89.1), and one quaternary (δC 41.7), respectively. The presence of 
two hydroxy groups in the molecule was shown by signals at δH 4.97 and 4.43 with no HSQC 
correlations. The 1H-1H COSY spectrum defined a geminal proton pair (δH 3.05 d, 2.10 d) [A], and three 
spin systems: –CH(OR)–CH–CH(OH)– (δH 5.75 d, 3.39 br d, 4.15 br s, 4.43 br s) [B], –CH(OR)–CH(OR)–
CH(OR)– (δH 5.49 br s, 4.99 br s, 5.12 br s) [C], and  
–CH=CH–CH(CH3)– (δH 6.04 d, 5.42 dd, 3.86 dq, 1.29 d) [D]. The HMBC correlations H3-16 with C-1, C-2 
(δC 89.1), and C-3 connected subunits A and B together. The cross-peaks between H-1b, H-3, 15-OH, 
and C-15 (δC 89.6) suggested that A and B are incorporated into a cyclopentane ring. In order to satisfy 
the 14 degree of unsaturation indicated by the molecular formula, structural parts B–D were 
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assembled into a 12-membered macrocycle. Heteronuclear correlations of H-5, 5-OH, H-7, H-8, and H-
17a/b with C-6 (δC 144.5), and of H-8, H-9, H-11, H-12, H3-18, and H3-19 with C-10 (δC 41.7) established 
a jatrophane scaffold. The long-range correlations of H-1a, H-13, H3-20, and 15-OH with the carbon at 
δC 212.4 required the keto group to be at C-14. The diagnostic interactions of oxymethines H-3, H-7, 
H-8, and H-9 with respective ester carbonyls at δC 169.4 (acetyl), 175.1 (isobutyryl), 170.4 (acetyl), and 
165.2 (benzoyl) determined the locations of the ester moieties. The second isobutyryl group could only 
be situated at C-2, because no three-bond HMBC correlation was observed between its carbonyl atom 
(δC 176.0) and protons of the terpenoid core. The hydrogens of 7-OiBu resonated in an upfield region 
than those of 2-OiBu (δH 1.84 sept, 0.87 d, 0.51 d, vs. 2.70 sept, 2 x 1.36 d), which was caused by the 
shielding effect of the C-9 benzoyl substituent. This phenomenon occurs when the ester group on C-7 
is parallel with an aromatic functional group at C-9, and therefore its chemical shifts are heavily 
influenced by the aromatic ring current effect.190 
The relative configuration of 19 was evaluated by a NOESY experiment. Concerning the NOEs between 
H-3/H-4, H-4/H-5, and H-4/H-7, the C-3 acetyl, C-5 hydroxy, and C-7 isobutyryl moieties were marked 
as β-oriented. From the NOE correlations between 5-OH/H3-16, 15-OH/H3-16, H-4/H-13, H-1α/H-13, 
and H-5/H-8, it was deduced that the methyls at C-2 and C-13, the 15-OH, and the 8-OAc groups occupy 
β-positions. A strong cross-peak from 5-OH to H-9 disclosed the α-position of the C-9 benzoyl group. 
The geminal methyls H3-18 and H3-19 were distinguished via the H-11/H-13, H-11/H3-19, H-12/H3-20, 
and H-12/H3-18 interactions. Interpretation of the coupling constants also offered valuable 
information regarding the conformation of the molecule. To start with, the E stereochemistry of the 
Δ11,12 double bond was dictated by the large value of 3JH11-12 (15.8 Hz). The small 3JH4-5 coupling constant 
(2.7 Hz), the NOE cross-peaks between H-4/H-7, H-5/H-8, together with the missing correlation of H-4 
with H-17, revealed the exo-conformation of the diterpenoid. 188,190 
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EGU-3 (20) 
The HRESIMS spectrum of (20, guyonianin H) gave the molecular formula C37H48O13 via the sodiated 
adduct ion at m/z 723.3022 [M + Na]+ (calcd 723.2993). The 1D NMR spectra displayed the signals of a 
benzoyl, an isobutyryl, and three acetyl groups besides the jatrophane skeleton. The absence of the 
upfield shifted protons of 7-OiBu indicated its replacement by an acetyl function. In a similar vein, the 
anisotropic effect of 9-OBz was demonstrated by the strongly shielded nature of the 7-OAc methyl (δH 
1.32 vs. δH 2.03 – 3-OAc, and δH 2.05 – 8-OAc). 
 
EDI-17 (21), EDI-18 (22), and EDI-19 (23) 
The 1H and 13C NMR data of compounds 21–23 were identical with those of kaempferol 3-O-
rhamnoside (21),191 quercetin 3-O-rhamnoside (22),192 and myricetin 3-O-rhamnoside (23),193 
respectively.  
 
5. Discussion 
In the last few decades considerable attention has been devoted to the possible applications of spurge 
species and their metabolites in the treatment of human diseases. According to Vasas et al., the 
probability of finding new macrocyclic diterpenoids is very high (almost 70% of the isolated compounds 
are newly discovered). Until 2014 approximately 100 Euphorbia species had been subjected to 
phytochemical analysis. Although the number of the investigated species comprise only less than 5% 
of the plants belonging to the genus, spurges have already provided numerous compounds with 
valuable therapeutic properties.91 For example, ingenol 3-angelate is approved for the treatment of 
actinic keratosis, considered as the most common pre-cancerous skin lesion. Tigilanol tiglate (EBC-46), 
isolated from the Australian native plant Fontainea picrosperma (blushwood tree), has recently been 
approved for the therapy of advanced solid tumors of companion animals. Moreover, EBC-46 applied 
as intratumoral injection has demonstrated encouraging results in a human phase I clinical trial 
evaluating its safety, tolerability and preliminary efficacy.194 Resiniferatoxin is a macrocyclic 
diterpenoid possessing a highly potent agonist activity towards the transient vanilloid receptor 1 
(TRPV1). In an ongoing phase I trial intrathecally administered reziniferatoxin is being evaluated for its 
ability to alleviate intractable pain associated with advanced cancer.195 Preliminary findings show that 
reziniferatoxin can selectively and irreversibly ablate nociceptive neurons, which could be used to 
control chronic pain.196 This diterpenoid is also investigated in a phase 3, randomized, multicentre, 
placebo-controlled study for its potential application in severe knee pain caused by osteoarthritis.197 
These data demonstrate why Euphorbia diterpenoids represent a hot topic in pharmacognosy, 
definitely considered as natural compounds worthy of further investigations.  
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Phytochemical investigations of E. dulcis, E. taurinensis, E. guyoniana, and E. davidii led to the isolation 
of 23 compounds. The structures of 20 diterpenoids, including 13 novel natural products, and 3 known 
flavonoid glycosides were established by NMR spectroscopy and HRESIMS measurements. Some of the 
isolated compounds exerted promising pharmacological (GIRK channel blocking, cytotoxic, and MDR 
modulating) activities. 
 
5.1. Isolation and purification of the diterpenoids and flavonoid glycosides 
Diterpenoids have previously been reported from various parts of Euphorbia species. Thus, the whole 
plants of E. dulcis and E. taurinensis, as well as all available aerial parts of E. guyoniana were processed 
in order to maximize the yields of compounds of interest. Structurally closely related diterpenoids 
display very similar chromatographic properties, hence their isolation is demanding and time-
consuming, and requires the application of multi-step chromatographic techniques. Since the 
diterpenoids are minor constituents of Euphorbia species, and only limited amounts of plant materials 
were accessible, the isolation procedures were carefully planned and performed under gentle 
conditions at neutral pH. This way the chemical decomposition of diterpenoids (e.g. hydrolysis of the 
ester bonds in an acidic environment) was successfully prevented, which would otherwise result in the 
formation of misleading artefacts. 
The fresh plant materials of E. dulcis and E. taurinensis were percolated with methanol at room 
temperature, while the dried sample of E. guyoniana was extracted with CHCl3 in an ultrasonic bath. 
Methanol is suitable for the extraction of a wide range of polar and apolar compounds because of its 
amphiphilic character. In the first step of separation, the diterpenoids of E. dulcis and E. taurinensis 
were enriched in CHCl3 by liquid-liquid partitioning. The concentrated crude extracts were 
chromatographed on polyamide columns with mixtures of MeOH–H2O. TLC analyses showed that the 
diterpenoids mostly accumulated in the fractions eluted with 60% and 80% aqueous MeOH. Rough 
separations of the diterpenoid-rich eluates were performed by silica gel VLC, then the collected 
fractions were pooled according to similarities in their diterpenoid compositions. The initial 
fractionation of E. dulcis and E. taurinensis still resulted in complex mixtures of diterpenoids, therefore 
further VLC steps were carried out before using more selective chromatographic methods. The proper 
and complete separation of the individual compounds was achieved by PLC and HPLC. 
In case of E. davidii, the MeOH extract was subjected to solvent-solvent extraction with CHCl3 and 
EtOAc. As the CHCl3-soluble fraction did not contain any compound worthy of an isolation attempt, the 
latter and more promising EtOAc phase was chosen for further separation. First, it was fractionated by 
VLC, then the flavonoid-rich subfractions were purified by PLC and HPLC. As a result of the isolation 
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procedures, the plant materials yielded 20 diterpenoids (1–11 from E. dulcis, 12–18 from E. taurinensis, 
and 19 and 20 from E. guyoniana) and 3 flavonoid glycosides (21–23 from E. davidii). 
 
5.2. Structure elucidation of the isolated compounds 
The diterpenoids were isolated as white amorphous solids, and the flavonoids as yellow powders. The 
molecular formulas of diterpenoids were determined by means of HRESIMS measurements. The 
indices of hydrogen deficiency calculated from the molecular formulas were taken into account, 
because they provided valuable information on the number of rings and double bonds present in the 
molecules. The flavonoids were identified by comparison of their 1H- and 13C NMR data with literature 
values. The structures of diterpenoids were established by 1D and 2D NMR spectroscopy. The 1H, 
JMOD, 1H-1H COSY, HSQC, and HMBC spectra revealed the constitutions of terpenoid scaffolds, then 
the relative configurations of stereogenic carbons were deduced by relevant NOESY correlations. As a 
result of the NMR studies, complete 1H- and 13C NMR assignments were made for the new natural 
products. In addition, the absolute configuration of compound 1 was determined using single-crystal 
X-ray diffraction. 
Fifteen of the isolated diterpenoids are based on jatrophane skeletons, while 3 were identified as 
ingenane, and 2 as segetane derivatives. Compounds 1–11 contain a Δ(5,6) olefinic bond instead of the 
regular Δ(6,17) double bond. The coupling constants between H-4 and H-5 (~10 Hz) are similar to the 
values previously reported for endo-conformers. Diagnostic NOE correlations of H-4 with H3-17 further 
confirmed that these diterpenoids adopted an endo-type conformation. Compounds 13 and 15 were 
also determined as endo-conformers based on their large 3JH4-5 coupling constants and indicative NOE 
interactions. Compounds 19 and 20 strongly prefer exo-conformations, corroborated by the small 3JH4-
5 coupling constants (~3 Hz), and by the results of the NOESY experiments. 
Compounds 1–20 are highly esterified with acetyl, benzoyl, tigloyl, angeloyl, isobutyryl, cinnamoyl, and 
acetoacetyl groups (see Annexes 5 and 6). The diterpenoids of E. dulcis differ only in their esterification 
patterns at C-7, C-8, C-9, C-14, and C-15, while at C-3 they contain a conserved benzoyl moiety. Tigloyl 
groups were found exclusively on C-7 and C-14. Compound 9, a structural isomer of euphomelliferene 
B, has C-14 hydroxy and C-15 acetyl functions. To date only a few jatrophanes have been reported with 
the same arrangement of substituents.124,187 The EUD-series is stereochemically homogeneous, 
characterized by a trans-fused ring system, 2β- and 13β-methyls, and 7β, 8β, 9α, 14β, and 15β acyl or 
hydroxy functions. Compounds 1 and 11 are not substituted at C-8. The new jatrophane diterpenoid 
13 has an α-acetyl group at C-9, while a structurally related diterpenoid from E. segetalis possesses a 
C-9 β-cinnamoyl group. Compounds 19 and 20 bear isobutyryl and acetyl functions at C-7 and, similarly 
to other jatrophanes reported from E. guyoniana, are esterified at C-2. 
40 
 
Segetanes represent a special class of diterpenoids: only 12 compounds had been isolated from 
E. segetalis, E. paralias, E. portlandica, and E. peplus prior to our work. Unlike the majority of 
segetanes, compound 12 bears a β-oriented acyl group at C-14, and the C-17 bridge is not substituted. 
Compounds 16–18 are known derivatives of ingenol. 
 
5.3. Chemotaxonomical aspects 
Macrocyclic diterpenoids are considered to be important taxonomic biomarkers because of their 
structural diversity and limited distribution in the plant kingdom. E. dulcis afforded a series of 
jatrophane diterpenoids bearing a Δ(5,6) olefinic bond instead of the more frequent 6(17)-exomethylene 
group. In fact, this structural feature has only been found in a minority of jatrophanes and, 
interestingly, most of those diterpenoids were isolated from spurge species of section Helioscopia of 
subgenus Esula,41 namely from E. helioscopia,114,132,151,187,198 E. mellifera,185 E. platyphyllos,29 E. 
gaditana,129 E. pubescens (syn. E. hirsuta),123,199 E. squamosa,136 E. stricta (syn. E. serrulata),24 and from 
E. dulcis in our study. Similar jatrophanes bearing a 6(17)-exomethylene moiety were reported from 
other sections as well (E. maddenii – sect. Arvales,200 E. lunulata – sect. Esula,186 and E. characias – sect. 
Patellares),75 and from one species of subgenus Euphorbia (Pedilanthus tithymaliodes,124,147 syn. E. 
tithymaloides – sect. Crepidaria).7 As the above data show, subgenus Esula of the genus Euphorbia is 
particularly rich in jatrophanes with a Δ(5,6) double bond, thus the presence of such compounds might 
be a useful chemotaxonomic marker for the characterization of members of this subgenus. 
Segetanes represent a unique group of diterpenoids with noteworthy chemotaxonomical aspects. 
According to an earlier classification, E. taurinensis and E. peplus were considered to be members of 
section Cymatospermum (Prokh.) Prokh., while E. segetalis, E. paralias, and E. portlandica belonged to 
the section Paralias Dumort.201 New phylogenetic studies suggest that E. taurinensis, E. segetalis, 
E. paralias, and E. portlandica belong to section Paralias.41,96 Our finding that E. taurinensis produces 
segetanes and no pepluanes strongly supports the new taxonomic classification of E. taurinensis. The 
close intra-generic relationships between E. taurinensis, E. segetalis, and E. paralias have also been 
demonstrated by similarities in their diterpenoid compositions: compounds 14, 16, and 17 have earlier 
been identified in both E. segetalis and E. paralias,118,155,156 while compounds 15 and 18 were described 
from E. segetalis.118 
Regarding E. guyoniana, it is the only representative of section Guyonianae in subgenus Esula.41 
Besides ent-abietane and atisane diterpenoids, numerous jatrophanes have been described from the 
plant. In previous studies plant materials of Algerian origin were investigated, while we have received 
the plant sample from Tunisia. The two isolated compounds (19 and 20) are not identical with any of 
the previously reported jatrophanes, which indicates the high chemical diversity of this species. 
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The latest classification suggests that E. davidii belongs to section Poinsettia of subgenus 
Chamaesyce.42 Diterpenoids have only been detected in species of section Anisophyllum, and this fact 
could provide a reasonable explanation to why we failed to obtain any diterpenoids from E. davidii in 
spite of our best efforts.96 The chemical constituents of E. taurinensis and E. davidii have not been 
investigated previously. Furthermore, all of the isolated diterpenoids and flavonoid glycosides are 
described for the first time in the investigated plants. 
 
5.4. Bioactivity of the isolated compounds and plant extracts 
Pharmacological investigations were performed in cooperation with Rytmion Ltd. (Szeged, Hungary) – 
ion channel blocking activity of the diterpenoids; the Department of Medical Microbiology and 
Immunobiology (University of Szeged, Szeged, Hungary) – MDR-reversing and cytotoxic activities of 
diterpenoids; and the Department of Pharmacodynamics and Biopharmacy (University of Szeged, 
Szeged, Hungary) – antiproliferative activity of plant extracts. 
 
5.4.1. Ion channel blocking activity of the diterpenoids 
Diterpenoids are characteristic secondary metabolites of the Euphorbia species, however, limited data 
are available on their cardiac effects. GIRK channels are involved in the fine electrical regulation of 
neurons, β-pancreatic cells, and atrial myocytes. It is suspected that malfunctions of GIRK channels 
contribute to the development of neuropathic pain, drug addiction, and cardiac arrhythmias. By 
prolonging atrial effective refractory period, the selective blockade of GIRK proteins appears to be a 
promising approach in searching for novel antiarrhythmic agents.202,203 hERG channels, frequently 
referred to as Kv 11.1, pass the rapid component of delayed rectifier K+ current, and thus influence the 
duration of the plateau phase, as well as the pacemaking activity of sinoatrial and atrioventricular node 
cells.204 The inhibition of hERG channels significantly elongates the QT interval on the 
electrocardiogram, which predisposes patients to life-threatening Torsades de Pointes (TdP) 
arrhythmias and, even worse, to sudden cardiac death. Plenty of structurally unrelated (e.g. 
psychiatric, antihistamine, antimicrobial, and antiarrhythmic) drugs have been reported to exhibit a 
strong affinity for the hERG channels.205 Due to the clinical importance of the proarrhythmogenic 
potential of commonly used pharmaceuticals, screening drug candidates for their hERG channel 
selectivity during preclinical safety assessments is a common practice nowadays.206 
Because of the serious disadvantages of current antiarrhythmic drugs (e.g. poor efficacy rate, lack of 
atrial specificity associated with an increased risk of side effects), many research efforts have been 
made to discover novel natural compounds with more selective effects on atrial ion channels. Vasas et 
al. reported that myrsinane, premyrsinane, and cyclomyrsinane diterpenoids isolated from E. falcata 
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exert a selective GIRK blocking activity,207 and this finding served as a motivation to explore the 
electrophysiological effects of the isolated diterpenoids. Compounds 1–12 and 15–20 were 
investigated on a stable transfected HEK-GIRK1/4 (Kir3.1/3.4) cell line using an automated patch-clamp 
equipment (the methodology of GIRK and hERG assays is available in detail in the corresponding paper 
published by Vasas et al.). The majority of the tested compounds were found to exert a significant 
inhibitory effect on the GIRK proteins at 10 μm, and some of them displayed a notable blocking activity 
even at 1 μm concentrations (Table 1). 
 
Table 1. Electrophysiological effects of compounds 1–12 and 15–20 on GIRK current in HEK-GIRK cells. 
 GIRK inhibition# (%) 
 Concentrations of the applied diterpenoids Propafenone* 
Compound 1 μM 10 μM 1 μM 
1 35.5 ± 5.6 88.7 ± 2.4 93.2 ± 1.7 
2 38.5 ± 3.5 85.0 ± 0.8 92.6 ± 3.2 
3 23.5 ± 0.3 35.7 ± 7.4 70.1 ± 5.9 
4 15.3 ± 2.7 60.8 ± 6.8 60.6 ± 2.6 
5 16.8 ± 2.1 66.6 ± 3.5 64.2 ± 2.5 
6 16.0 ± 10.2 26.8 ± 6.9 65.2 ± 3.4 
7 11.2 ± 6.3 23.5 ± 3.3 72.7 ± 1.5 
8 15.7 ± 9.0 25.7 ± 1.7 69.4 ± 3.0 
9 27.2 ± 4.8 66.0 ± 8.2 76.3 ± 6.7 
10 33.8 ± 4.9 83.4 ± 0.6 94.2 ± 2.4 
11 31.1 ± 1.9 78.7 ± 6.1 74.7 ± 6.2 
12 17.7 ± 1.3 28.6 ± 2.8 68.0 ± 5.0 
15 22.2 ± 5.8 23.7 ± 8.1 61.2 ± 2.5 
16 23.8 ± 11.4 52.3 ± 5.4 75.8 ± 2.5 
17 43.9 ± 13.8 80.4 ± 0.3 83.8 ± 1.4 
18 16.4 ± 4.3 45.1 ± 5.4 70.6 ± 1.2 
19 19.2 ± 1.4 70.4 ± 4.2 73.1 ± 4.1 
20 20.3 ± 8.1 48.4 ± 4.3 58.1 ± 3.0 
#Results are means ± SEM, n = 2-3; *: positive control 
 
The IC50 values were calculated from the dose-response curves (Appendix I). Compounds 1 and 17 were 
the most effective diterpenoids, with IC50 values of 1.3 ± 0.2 and 1.5 ± 0.1 µM, respectively. The IC50 
values of compounds 2 and 10 were similar (1.6 ± 0.2 and 1.7 ± 0.2 μM, respectively). The IC50 values 
were determined as 2.6 ± 0.5 µM for compound 11, 3.4 ± 0.1 µM for compound 9, and 12.2 ± 0.5 µM 
for compound 16. These jatrophane and ingenane diterpenoids were tested for their hERG-related 
cardiotoxicity on HEK-hERG (Kv11.1) cells. The presented data demonstrate that none of the 
jatrophanes interfered with the function of the hERG proteins, however, the outward K+ flow was 
strongly hampered by compound 17 (Table 2). 
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Table 2. hERG inhibitory effects of the selected diterpenoids. 
 hERG inhibition# (%) 
 Concentrations of the applied diterpenoids Amitriptyline* 
Compound 1 μM 10 μM 10 μM 
1 10.8 ± 5.7 24.9 ± 6.4 97.7 ± 0.8 
2 6.5 ± 5.2 24.4 ± 2.0 99.1 ± 0.9 
9 11.2 ± 0.6 22.7 ± 2.6 99.3 ± 0.7 
10 13.2 ± 2.2 24.0 ± 1.8 98.1 ± 0.5 
11 3.3 ± 1.5 19.0 ± 0.5 99.3 ± 0.7 
16 1.8 ± 0.4 7.9 ± 1.0 99.2 ± 0.8 
17 11.2 ± 0.1 55.4 ± 0.4 100.0 ± 0.0 
#Results are means ± SEM, n = 2-3; *: positive control 
 
Our investigations focusing on the GIRK channels showed no clear correlations between the inhibitory 
effect and the substitution patterns, so unfortunately, we could not establish any structure-activity 
relationships for the EUD-series. Nevertheless, jatrophane and ingenane diterpenoids were proven to 
be potent inhibitors of the atrial GIRK proteins. In case of the hERG experiment, a substantial difference 
was found between the effectiveness of compounds 16 and 17; the latter ingenane contains an 
angeloyl group at C-17, which might influence the affinity of that compound towards the hERG 
channels, although this piece of data is not enough to draw firm conclusions. Further investigations 
are required to obtain a deeper insight into how the structural characteristics of Euphorbia 
diterpenoids affect their interactions with the pharmacologically important GIRK and hERG channels. 
 
5.4.2. MDR-reversing and cytotoxic activities of diterpenoids isolated from E. taurinensis 
The development of multidrug resistance is a principal reason behind the failure of chemotherapy. The 
MDR phenotype is associated with the overexpression of ATP-binding casette (ABC) transporters, 
including P-glycoprotein (P-gp/ABCB1), multidrug resistance protein (MRP1/ABCC1) and breast cancer 
resistance protein (BCRP/ABCG2). These membrane-associated efflux proteins are able to recognize 
and extrude numerous structurally unrelated anticancer drugs. Possible ways of overcoming MDR have 
been extensively investigated, but no breakthroughs have been achieved until today. 
Euphorbia diterpenoids are best known for their strong MDR-reversing activities. Therefore, we 
examined the P-gp modulating and cytotoxic properties of compounds 12 and 15–18 on an L5178 
mouse lymphoma cell line using rhodamine 123 accumulation and MTT cell viability assays (Appendix 
II). Retention of rhodamine 123 was measured by flow cytometry, and the fluorescence activity ratio 
(FAR) was calculated using the following equation: 𝐹𝐴𝑅 =  
𝐹𝐼𝑀𝐷𝑅 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝐹𝐼𝑀𝐷𝑅 𝑐𝑜𝑛𝑡𝑟𝑜𝑙⁄
𝐹𝐼𝑃𝐴𝑅 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝐹𝐼𝑃𝐴𝑅 𝑐𝑜𝑛𝑡𝑟𝑜𝑙⁄
. FI represents the 
fluorescence intensities observed for MDR1 gene-transfected and drug-sensitive parent cell lines in 
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the presence (treated) and absence (control) of the analyte. Compared to the positive control 
verapamil, all of the compounds were found to inhibit the P-gp efflux pump on the resistant mouse T-
lymphoma cells (Figure 13). Compounds 12, 17, and 18 were shown to be the most powerful 
modulators at a concentration of 20 μM, with an efficacy of 7-9-fold higher compared to verapamil 
(FAR: 44.44, 59.36, and 56.16, respectively). 
 
 
Figure 13. Efflux pump modulating activities of the tested diterpenoids. 
 
Cell growth was determined by measuring the optical density at 550 nm with a multiscan EX ELISA 
reader. The results of the MTT assay are summarized in Table 3. Based on our findings, neither the 
segetane, nor the jatrophane diterpenoids tested exert any cytotoxic activity on the sensitive parent 
and on the resistant MDR cells. In contrast, the ingenane diterpenoids 17 and 18 displayed a cytotoxic 
effect on both cell lines. The IC50 values of the most active compound 17 on the two cell lines were 
almost equal, indicating that it has no selectivity towards the resistant cell line, while compound 18 
was more potent on the resistant cell line. The presence of a larger ester function at C-17 might 
enhance the cytotoxicity of the ingenanes, however, further data are needed to confirm this 
speculation. 
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Table 3. Cytotoxic activities of compounds 12 and 15–18 on parent and MDR mouse T-lymphoma cells. 
 Parent mouse T-lymphoma cell line MDR mouse T-lymphoma cell line 
Compound IC50 (μM) CI# IC50 (μM) 95% CI 
12 > 100 - > 100 - 
15 > 100 - > 100 - 
16 > 100 - > 100 - 
17 53.35 51.34–55.36 59.83 58.25–61.41 
18 82.47 80.38–84.56 62.81 61.65–63.97 
Doxorubicin* 0.7 0.42–0.98 2.14 1.76–2.52 
#: 95% confidence interval, n = 3; *: positive control 
 
5.4.3. Antiproliferative activities of the extracts of E. davidii 
The prepared extracts (n-hexane, CHCl3, EtOAc, 50% MeOH residue, H2O) were screened in vitro for 
their antiproliferative activity against HeLa (cervix epithelial adenocarcinoma), MCF7 (breast epithelial 
adenocarcinoma), A2780 (ovarian carcinoma), and A431 (skin epidermoid carcinoma) cell lines using 
the MTT assay (Table 4). Cisplatin was applied as a reference compound.208 The n-hexane and CHCl3 
extracts were found to exhibit a dose-dependent cell growth inhibitory activity on all cell lines. The 
flavonoid-rich EtOAc fraction did not inhibit the proliferation of any cancer cell lines. 
 
Table 4. Antiproliferative effects of the prepared extracts against selected cancer cell lines. 
Extracts 
Concentration. 
(μg/mL) 
Inhibition of cell growth# (%) 
HeLa MCF7 A2780 A431 
n-Hexane 
10 14.6 ± 1.8 33.1 ± 2.0 19.4 ± 1.4 18.1 ± 0.8 
30 22.4 ± 2.7 45.9 ± 1.6 26.7 ± 0.9 25.7 ± 3.0 
Chloroform 
10 –* 30.8 ± 2.2 21.8 ± 0.7 – 
30 22.3 ± 2.7 52.6 ± 0.9 47.1 ± 0.7 21.6 ± 0.4 
Ethyl acetate 
10 – – – – 
30 – – – – 
50% Methanol 
10 – – – – 
30 – 15.8 ± 2.3 – – 
Water 
10 – – – – 
30 – 27.9 ± 1.9 15.2 ± 0.8 – 
Cisplatin 
10 42.6 ± 2.3 66.9 ± 1.8 83.6 ± 1.2 88.5 ± 0.5 
30 99.9 ± 0.3 96.8 ± 0.4 95.0 ± 0.3 90.2 ± 1.8 
#: Results are mean ± SEM, n = 5; *: Extracts displaying less than 10% inhibition of cancer cell proliferation were 
regarded as ineffective, and therefore the values are omitted.  
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6. Summary 
The present work covered the phytochemical analysis of four spurge species, namely E. dulcis, 
E. taurinensis, E. guyoniana, and E. davidii, the isolation and structure determination of their 
diterpenoids and flavonoids, and the pharmacological investigations of extracts and compounds of 
these species. The isolation and purification procedures were carried out by multi-step 
chromatographic techniques, involving polyamide OCC, VLC, PLC, and HPLC on NP and RP silica gel. The 
structures of the isolated compounds were elucidated by means of HRESIMS, 1D (1H, JMOD) and 2D 
(HSQC, HMBC, 1H-1H COSY, NOESY) NMR experiments. Interpretation of the spectral data allowed the 
complete and unambiguous 1H- and 13C assignments of the novel diterpenoids. In addition, the 
absolute configuration of compound 1 was determined by single-crystal X-ray diffraction. 
The MeOH extract of E. dulcis yielded nine novel (1–9) and two known (10 and 11) jatrophane 
diterpenoids. The diterpenoids possess a Δ(5,6) double bond, and are highly esterified with benzoic-, 
tiglic-, and acetic acids. Moreover, compound 9 was found to be an interesting structural isomer of 
euphomelliferene B. The compounds isolated from E. dulcis represent a stereochemically 
homogeneous series of diterpenoids with different substitution patterns. The diterpenoids were found 
to adopt endo-type conformations, as dictated by diagnostic coupling constant values and NOESY 
cross-peaks. The chemical composition of E. dulcis revealed its close relationship with other members 
of section Helioscopia of subgenus Esula. 
The MeOH extract of E. taurinensis afforded seven diterpenoids with various parent skeletons, 
including a novel and a known segetane (12 and 14, respectively), a novel and a known jatrophane (13 
and 15, respectively), and 3 known ingenanes (16–18). Unlike most of the previously described 
segetanes, compound 12 contains a β-oriented acetyl group at C-14 and is not substituted at C-17. 
Compounds 13 and 15 preferentially adopt endo-type conformations, and only differ in the 
esterification and relative configuration of C-9. The presence of segetane diterpenoids in E. taurinensis 
supports the latest chemotaxonomic classification of this spurge species. 
As a result of our research, 2 novel jatrophane diterpenoids (19 and 20) were isolated from the MeOH 
extract of E. guyoniana. The polyhydroxylated cores of the molecules are esterified with benzoyl-, 
acetyl-, and isobutyryl groups. The exo-conformation of the diterpenoids was apparent from their NMR 
spectral properties. Ent-abietanes and jatrophanes are characteristic secondary metabolites of the 
plant, however, compounds 19 and 20 are not identical with previously reported diterpenoids. This 
finding suggests a great variation in the diterpenoid compositions of populations of E. guyoniana 
grown at different geographical locations. 
The EtOAc phase of the MeOH extract of E. davidii yielded 3 ubiquitous flavonoid glycosides (the 3-O-
rhamnosides of kaempferol, quercetin, and myricetin), however, we failed to obtain any diterpenoids 
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from the plant material. The absence of diterpenoids in this invasive weed is not surprising in the light 
of literature data; the sporadic occurrence of diterpenoids in subgenus Chamaesyce have only been 
described in members of section Anisophyllum, while E. davidii belongs to section Poinsettia. 
The biological activities of the isolated diterpenoids and some of the plant extracts were investigated 
in collaboration with of our cooperative partners. Compounds 1–12 and 15–20 were studied on a 
stable transfected HEK-GIRK1/4 cell line, and the effect of diterpenoids on inward K+ currents was 
measured by an automated patch-clamp equipment. Compounds 1, 2, 9, 10, 11, 16, and 17, exerting 
the most pronounced inhibitory effects, were tested on HEK-hERG cells. The results demonstrated that 
while jatrophanes are potent blockers of the atrial GIRK channels, their interactions with hERG proteins 
are negligible. Significant inhibition of the hERG channels was only observed for compound 17. To the 
best of our knowledge, our group is the first one to evaluate the electrophysiological effects of 
jatrophanes, segetanes, and ingenanes on GIRK and hERG proteins. Considering the selective activities 
of jatrophanes, they may represent a group of potential lead compounds for the development of novel 
therapeutic agents against atrial fibrillation. Diterpenoids of different skeletons isolated from E. 
taurinensis exerted notable MDR-reversing activities in an L5178 mouse lymphoma cell line. The novel 
segetane compound (12), as well as two ingenanes (17 and 18) were shown to be the most powerful 
among the tested diterpenoids, reaching an efficacy of 7-9-fold higher compared to the positive 
control verapamil. The ingenanes 17 and 18 were cytotoxic, while the segetanes and jatrophanes were 
ineffective in the cytotoxicity assay. Furthermore, the n-hexane and CHCl3 extracts of E. davidii 
exhibited a weak to moderate, dose-dependent cell growth inhibitory activity on four carcinoma cell 
lines. 
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